https://curecurrent.com/trials/early-screening-and-treatment-of-women-with-prediabetes-in-pregnancy-5001https://curecurrent.com/trials/aggressive-versus-conservative-blood-glucose-control-in-hospitalized-type-2-diabetic-patients-using-detemir-and-aspart-i-5002https://curecurrent.com/trials/the-impact-of-low-fat-and-full-fat-dairy-consumption-on-glucose-homeostasis-dairy-study-5003https://curecurrent.com/trials/tedizolid-tissue-penetration-in-diabetic-patients-with-wound-infections-and-healthy-volunteers-via-in-vivo-microdialysis-5004https://curecurrent.com/trials/tissue-penetration-of-ceftolozane-tazobactam-in-diabetic-patients-with-lower-limb-infections-5005https://curecurrent.com/trials/changes-in-adiposity-metabolic-measures-from-atypicals-to-aripiprazole-5006https://curecurrent.com/trials/coordinating-and-data-management-center-for-the-consortium-for-the-study-of-chronic-pancreatitis-diabetes-and-pancreatic-5007https://curecurrent.com/trials/obtaining-and-storing-standard-of-care-wound-biopsies-for-immediate-or-future-wound-related-scientific-study-5008https://curecurrent.com/trials/determining-dietary-pattern-accompanying-egg-intake-using-remote-food-photography-method-5009https://curecurrent.com/trials/safety-and-efficacy-of-evolocumab-in-combination-with-statin-therapy-in-adults-with-diabetes-and-hyperlipidemia-or-mixed-5010https://curecurrent.com/trials/closed-loop-glucagon-administration-for-hypoglycemia-treatment-5011https://curecurrent.com/trials/use-of-the-insulin-pump-in-cystic-fibrosis-patients-with-impaired-glucose-tolerance-or-cfrd-and-in-type-1-diabetes-patie-5012https://curecurrent.com/trials/can-group-visits-improve-outcomes-of-veterans-with-diabetes-5013https://curecurrent.com/trials/mil-familias-santa-barbara-s-operational-pilot-to-understand-diabetes-in-the-latino-community-5014https://curecurrent.com/trials/an-add-on-study-of-mlr-1023-in-adults-with-uncontrolled-type-2-diabetes-on-metformin-therapy-5015https://curecurrent.com/trials/free-fatty-acids-induced-hypertension-in-obese-subjects-aim-2-5016https://curecurrent.com/trials/phase-iii-study-to-evaluate-safety-and-efficacy-of-added-exenatide-versus-placebo-to-titrated-basal-insulin-glargine-in-5017https://curecurrent.com/trials/efficacy-of-pramlintide-on-prevention-of-weight-gain-early-onset-of-type-1-diabetes-5018https://curecurrent.com/trials/a-study-on-the-effects-of-ly2409021-on-the-electrical-impulses-of-the-heart-5019https://curecurrent.com/trials/intrapartum-glucose-management-among-women-with-gestational-diabetes-mellitus-5020https://curecurrent.com/trials/empagliflozin-as-adjunctive-to-insulin-therapy-over-52-weeks-in-patients-with-type-1-diabetes-mellitus-ease-2-5021https://curecurrent.com/trials/a-trial-comparing-the-efficacy-and-safety-of-insulin-degludec-liraglutide-versus-insulin-glargine-in-subjects-with-type-5022https://curecurrent.com/trials/a-trial-comparing-the-efficacy-and-safety-of-insulin-degludec-liraglutide-and-insulin-degludec-in-subjects-with-type-2-d-5023https://curecurrent.com/trials/the-efficacy-of-insulin-degludec-liraglutide-in-controlling-glycaemia-in-adults-with-type-2-diabetes-inadequately-contro-5024https://curecurrent.com/trials/a-trial-comparing-the-safety-and-efficacy-of-insulin-degludec-and-insulin-glargine-both-with-insulin-aspart-as-mealtime-5025https://curecurrent.com/trials/phase-3-28-week-study-with-24-week-and-52-week-extension-phases-to-evaluate-efficacy-and-safety-of-exenatide-once-weekly-5026https://curecurrent.com/trials/evaluation-of-the-dexcom-g6-continuous-glucose-monitoring-system-with-a-non-interferent-sensor-5027https://curecurrent.com/trials/effectiveness-and-safety-of-the-dexcom-g6-continuous-glucose-monitoring-system-5028https://curecurrent.com/trials/study-to-assess-the-safety-pharmacokinetics-and-pharmacodynamics-of-ds-1150b-in-healthy-subjects-and-subjects-with-type-5029https://curecurrent.com/trials/health-coach-program-to-improve-chronic-disease-outcomes-following-an-emergency-department-visit-5030https://curecurrent.com/trials/a-subjective-observational-study-of-patients-using-medicated-footbath-footwash-treatment-in-podiatry-care-5031https://curecurrent.com/trials/web-based-intervention-designed-to-educate-and-improve-adherence-through-learning-to-use-continuous-glucose-monitoring-5032https://curecurrent.com/trials/the-impact-of-mobile-technology-on-clinical-outcomes-in-children-and-adolescents-with-type-1-diabetes-5033https://curecurrent.com/trials/side-effects-of-newer-antipsychotics-in-older-adults-5034https://curecurrent.com/trials/ivacaftor-kalydeco-and-insulin-in-cystic-fibrosis-cf-5035https://curecurrent.com/trials/rhubarb-and-angiotensin-converting-enzyme-inhibitor-5036https://curecurrent.com/trials/controlling-hypertension-in-diabetes-feasibility-study-5037https://curecurrent.com/trials/a-low-carbohydrate-diabetes-prevention-program-5038https://curecurrent.com/trials/a-study-of-the-effects-of-canagliflozin-jnj-28431754-on-renal-endpoints-in-adult-participants-with-type-2-diabetes-melli-5039https://curecurrent.com/trials/a-study-of-ly3209590-in-participants-with-type-2-diabetes-5040https://curecurrent.com/trials/a-24-week-open-label-phase-3b-trial-with-a-28-week-extension-to-evaluate-the-efficacy-and-safety-of-saxagliptin-co-admin-5041https://curecurrent.com/trials/digital-ankle-brachial-index-abi-as-a-screening-tool-in-detecting-peripheral-arterial-disease-5042https://curecurrent.com/trials/screening-of-subjects-with-type-i-diabetes-to-determine-eligibility-for-islet-transplantation-5043https://curecurrent.com/trials/glucose-response-of-g-pen-glucagon-injection-in-pediatric-t1d-patients-5044https://curecurrent.com/trials/genetics-and-markers-of-degenerative-and-inflammatory-eye-diseases-5045https://curecurrent.com/trials/canvas-canagliflozin-cardiovascular-assessment-study-5046https://curecurrent.com/trials/dipeptidyl-peptidase-4-inhibitor-sitagliptin-therapy-in-the-inpatients-with-type-2-diabetes-5047https://curecurrent.com/trials/evaluation-of-effect-of-doxycycline-verses-placebo-on-retinal-function-and-diabetic-retinopathy-5048https://curecurrent.com/trials/freestyle-libre-flash-glucose-monitoring-system-5049https://curecurrent.com/trials/utility-of-hemoglobin-a1c-for-the-diagnosis-of-gestational-diabetes-5050https://curecurrent.com/trials/metformin-versus-insulin-in-pregnant-women-with-type-2-diabetes-5051https://curecurrent.com/trials/metformin-postpartum-for-gdm-rct-for-reduced-weight-retention-5052https://curecurrent.com/trials/the-set-point-study-evaluating-effects-of-changing-glucose-target-on-bionic-pancreas-performance-5053https://curecurrent.com/trials/demonstrate-the-effects-of-pramlintide-on-weight-reduction-in-schizophrenia-5054https://curecurrent.com/trials/a-study-of-ly2608204-in-patients-with-type-2-diabetes-5055https://curecurrent.com/trials/a-multi-center-trial-to-evaluate-the-safety-and-efficacy-of-pegaptanib-sodium-macugen-injected-into-the-eye-every-6-week-5056https://curecurrent.com/trials/effect-of-pharmacists-treating-diabetes-in-a-fqhc-5057https://curecurrent.com/trials/a-study-to-estimate-the-effect-of-repeated-dosing-of-pf-05175157-on-the-pharmacokinetics-of-a-single-dose-of-simvastatin-5058https://curecurrent.com/trials/diabetes-engagement-and-activation-platform-5059https://curecurrent.com/trials/the-role-of-non-alcoholic-fatty-liver-disease-in-gestational-diabetes-5060https://curecurrent.com/trials/home-exercise-to-enhance-mobility-for-older-diabetics-5061https://curecurrent.com/trials/efficacy-of-amlexanox-vs-placebo-in-type-2-diabetic-patients-5062https://curecurrent.com/trials/consistent-1-metabolic-and-safety-outcomes-of-hylenex-recombinant-hyaluronidase-human-injection-preadministered-at-csii-5063https://curecurrent.com/trials/effects-of-aromatase-inhibition-versus-testosterone-in-older-men-with-low-testosterone-randomized-controlled-trial-5064https://curecurrent.com/trials/harnessing-mhealth-and-social-support-to-improve-diabetes-related-health-behavior-for-inner-city-patients-5065https://curecurrent.com/trials/study-of-the-safety-and-tolerability-of-switching-to-itca-650-in-patients-with-type-2-diabetes-receiving-liraglutide-5066https://curecurrent.com/trials/aldosterone-and-the-metabolic-syndrome-5067https://curecurrent.com/trials/empagliflozin-as-adjunctive-to-insulin-therapy-over-26-weeks-in-patients-with-t1dm-ease-3-5068https://curecurrent.com/trials/modulation-of-stat3-signaling-with-siltuximab-in-type-1-diabetes-5069https://curecurrent.com/trials/retrospective-evaluation-of-athens-complete-health-improvement-program-chip-database-5070https://curecurrent.com/trials/effect-of-a-fixed-pramlintide-insulin-dose-ratio-on-postprandial-glucose-in-type-1-diabetes-mellitus-5071https://curecurrent.com/trials/evaluation-of-doxycycline-verses-placebo-for-the-treatment-of-severe-nonproliferative-or-mild-or-moderate-proliferative-5072https://curecurrent.com/trials/provider-initiated-regular-remote-interventions-for-optimal-type-2-diabetes-care-5073https://curecurrent.com/trials/a-study-to-compare-the-effects-of-insulin-peglispro-and-glargine-on-insulin-sensitivity-and-meal-time-insulin-requiremen-5074https://curecurrent.com/trials/pf-06291874-multiple-ascending-dose-study-in-type-2-diabetes-mellitus-patients-5075https://curecurrent.com/trials/satisfaction-of-treatment-among-elderly-patients-with-insulin-therapy-5076https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-dapagliflozin-on-blood-glucose-level-and-renal-safety-in-patients-with-type-2-diabetes-5077https://curecurrent.com/trials/safety-and-efficacy-of-g-pen-compared-to-lilly-glucagon-for-hypoglycemia-rescue-in-adult-type-1-diabetics-5078https://curecurrent.com/trials/trial-between-a-computer-guided-insulin-infusion-protocol-versus-a-standard-insulin-infusion-algorithm-in-medical-icu-5079https://curecurrent.com/trials/pilot-study-3-of-outpatient-control-to-range-safety-and-efficacy-with-day-and-night-in-home-use-5080https://curecurrent.com/trials/women-s-lifestyle-balance-study-5081https://curecurrent.com/trials/evaluation-of-a-prototype-diabetes-management-system-applied-to-insulin-initiation-and-titration-5082https://curecurrent.com/trials/resveratrol-and-the-metabolic-syndrome-5083https://curecurrent.com/trials/weight-loss-using-a-feedback-device-in-obese-people-with-the-metabolic-syndrome-5084https://curecurrent.com/trials/direct-antibiotic-delivery-of-cefazolin-into-soft-tissue-infections-using-subcutaneous-injection-and-ultrasonic-dispersi-5085https://curecurrent.com/trials/mhealth-intervention-for-older-adults-5086https://curecurrent.com/trials/n-acetylcysteine-and-milk-thistle-for-treatment-of-diabetic-nephropathy-5087https://curecurrent.com/trials/comparing-self-monitored-blood-glucose-smbg-to-continuous-glucose-monitoring-cgm-in-type-2-diabetes-5088https://curecurrent.com/trials/guided-imagery-lifestyle-intervention-to-promote-health-and-prevent-diabetes-in-youth-5089https://curecurrent.com/trials/miami-healthy-heart-initiative-a-behavioral-study-on-cardiovascular-risk-factors-5090https://curecurrent.com/trials/study-to-evaluate-if-the-drug-vasopressin-protects-the-kidneys-for-patients-undergoing-liver-transplant-5091https://curecurrent.com/trials/maptrek-to-increase-activity-among-patients-at-risk-for-type-2-diabetes-5092https://curecurrent.com/trials/the-create-wellness-study-5093https://curecurrent.com/trials/a-phase-1-single-multiple-dose-study-of-pf-06293620-to-assess-safety-tolerability-and-pharmacokinetics-in-subjects-with-5094https://curecurrent.com/trials/motion-perception-in-individuals-with-type-2-diabetes-5095https://curecurrent.com/trials/novel-therapies-for-metabolic-complications-of-lipodystrophies-5096https://curecurrent.com/trials/impact-of-vitamin-d-on-diabetic-kidney-disease-in-african-americans-5097https://curecurrent.com/trials/pathobiology-and-reversibility-of-prediabetes-in-a-biracial-cohort-5098https://curecurrent.com/trials/mechanism-underlying-beta-cell-failure-in-obese-african-americans-with-history-of-hyperglycemic-crises-5099https://curecurrent.com/trials/continuous-glucose-monitoring-to-assess-glycemia-in-chronic-kidney-disease-changing-glucose-management-5100https://curecurrent.com/trials/coalition-for-a-healthier-community-utah-women-and-girls-phase-ii-uwag-ii-5101https://curecurrent.com/trials/basal-bolus-versus-basal-insulin-in-type-2-diabetes-mellitus-t2dm-5102https://curecurrent.com/trials/treating-prediabetes-in-the-first-trimester-5103https://curecurrent.com/trials/getting-in-balance-a-workplace-diabetes-prevention-intervention-trial-5104https://curecurrent.com/trials/a-multi-center-randomized-double-blind-phase-iii-trial-to-evaluate-the-safety-and-efficacy-of-saxagliptin-co-administere-5105https://curecurrent.com/trials/efficacy-safety-trial-of-intravitreal-injections-combined-with-prp-for-csme-secondary-to-diabetes-mellitus-dave-5106https://curecurrent.com/trials/efficacy-and-safety-of-switching-from-sitagliptin-to-liraglutide-in-subjects-with-type-2-diabetes-not-achieving-adequate-5107https://curecurrent.com/trials/safety-and-efficacy-of-exubera-compared-with-subcutaneous-human-insulin-therapy-in-children-and-adolescents-5108https://curecurrent.com/trials/fit-and-trim-for-diabetes-prevention-5109https://curecurrent.com/trials/cep249-pediatric-accuracy-study-5110https://curecurrent.com/trials/basal-insulin-in-the-management-of-patients-with-diabetic-ketoacidosis-dka-5111https://curecurrent.com/trials/free-fatty-acids-and-vascular-function-in-subjects-with-diabetes-5112https://curecurrent.com/trials/trial-of-dehydrated-human-amnion-chorion-membrane-dhacm-in-the-management-of-diabetic-foot-ulcers-5113https://curecurrent.com/trials/reducing-risks-and-improving-glucose-control-during-extended-exercise-in-youth-with-t1dm-the-ap-ski-camp-5114https://curecurrent.com/trials/multidisciplinary-team-approach-working-together-to-improve-glycemic-control-in-hispanic-adults-diabetes-5115https://curecurrent.com/trials/periodontal-treatment-response-in-type-ii-diabetic-patients-5116https://curecurrent.com/trials/efficacy-and-safety-of-toujeo-versus-tresiba-in-insulin-naive-patients-with-type-2-diabetes-mellitus-inadequately-contro-5117https://curecurrent.com/trials/four-way-crossover-closed-loop-with-exercise-detection-5118https://curecurrent.com/trials/dapagliflozin-evaluation-in-patients-with-inadequately-controlled-type-1-diabetes-5119https://curecurrent.com/trials/impact-of-exenatide-on-sleep-in-type-2-diabetes-5120https://curecurrent.com/trials/prevalence-of-non-alcoholic-fatty-liver-disease-nafld-in-hispanics-with-diabetes-mellitus-type-2-t2dm-and-role-of-treatm-5121https://curecurrent.com/trials/diabetic-retinopathy-in-hiv-subjects-treated-with-egrifta-5122https://curecurrent.com/trials/threshold-suspend-in-pediatrics-at-home-5123https://curecurrent.com/trials/neuropathic-investigation-and-anticholinergic-treatment-of-bladder-dysfunction-in-diabetes-and-stroke-patients-5124https://curecurrent.com/trials/three-way-interaction-between-gabapentin-duloxetine-and-donepezil-in-patients-with-diabetic-neuropathy-5125https://curecurrent.com/trials/use-of-continuous-glucose-sensors-by-adolescents-with-inadequate-diabetic-control-5126https://curecurrent.com/trials/physical-and-cognitive-function-look-ahead-ancillary-study-5127https://curecurrent.com/trials/a-trial-investigating-the-efficacy-and-safety-of-insulin-detemir-versus-insulin-nph-in-combination-with-metformin-and-di-5128https://curecurrent.com/trials/study-of-efficacy-and-tolerability-of-various-bowel-preps-in-diabetic-patients-5129https://curecurrent.com/trials/hypoglycemia-in-hospitalized-patients-5130https://curecurrent.com/trials/study-of-alemtuzumab-versus-anti-thymocyte-globulin-to-help-prevent-rejection-in-kidney-and-pancreas-transplantation-5131https://curecurrent.com/trials/impact-of-non-glucose-signals-on-glycemic-control-in-patients-with-type-1-diabetes-5132https://curecurrent.com/trials/safety-and-feasibility-evaluation-of-the-aps-app-5133https://curecurrent.com/trials/safety-of-inhaled-preprandial-human-insulin-in-subjects-with-diabetes-and-asthma-5134https://curecurrent.com/trials/healthyme-online-weight-management-education-healthyme-at-home-5135https://curecurrent.com/trials/effect-of-inhaled-insulin-aerx-idms-on-blood-glucose-control-in-type-2-diabetes-5136https://curecurrent.com/trials/a-clinical-study-to-investigate-and-compare-the-impact-of-high-protein-pasta-lower-protein-pasta-and-white-rice-on-blood-5137https://curecurrent.com/trials/evaluating-weight-loss-programs-for-obese-people-at-risk-for-heart-disease-the-power-study-5138https://curecurrent.com/trials/effect-of-inhaled-pre-prandial-human-insulin-on-blood-glucose-control-in-type-2-diabetes-5139https://curecurrent.com/trials/safety-and-efficacy-of-inhaled-insulin-in-type-1-diabetes-5140https://curecurrent.com/trials/study-of-human-plasma-derived-alpha1-proteinase-inhibitor-in-subjects-with-new-onset-type-1-diabetes-mellitus-5141https://curecurrent.com/trials/effects-of-roflumilast-on-insulin-and-blood-sugar-levels-in-prediabetic-overweight-and-obese-individuals-5142https://curecurrent.com/trials/effects-of-fatty-acid-delivery-on-heart-metabolism-and-function-in-type-2-diabetes-t2dm-5143https://curecurrent.com/trials/environmental-polymorphisms-registry-health-and-exposures-survey-5144https://curecurrent.com/trials/pioglitazone-and-serum-asymmetric-dimethylarginine-adma-in-patients-with-diabetes-5145https://curecurrent.com/trials/evaluation-of-evolocumab-amg-145-efficacy-in-diabetic-adults-with-hypercholesterolemia-mixed-dyslipidemia-5146https://curecurrent.com/trials/treatment-of-type-2-diabetes-with-ketogenic-diet-5147https://curecurrent.com/trials/safety-study-of-ge-145-320-mg-i-ml-injection-vs-iopamidol-370-mg-i-ml-in-elderly-subjects-undergoing-coronary-procedure-5148https://curecurrent.com/trials/assessment-of-intranasal-glucagon-in-children-and-adolescents-with-type-1-diabetes-5149https://curecurrent.com/trials/to-evaluate-if-wide-blood-sugar-fluctuations-lead-to-injury-of-heart-function-and-heart-nerves-5150https://curecurrent.com/trials/effect-of-dpp4-inhibition-on-vasoconstriction-5151https://curecurrent.com/trials/study-of-subjects-with-diabetic-foot-ulcer-dfu-5152https://curecurrent.com/trials/heat-therapy-and-cardiometabolic-health-in-obese-women-5153https://curecurrent.com/trials/the-effect-of-nutrient-intake-on-the-microbiome-weight-and-glucoregulation-ni-mwg-5154https://curecurrent.com/trials/ada-linagliptin-in-long-term-care-5155https://curecurrent.com/trials/liraglutide-versus-insulin-mono-therapy-in-the-closed-loop-setting-5156https://curecurrent.com/trials/ketogenic-diet-treatment-of-obesity-with-co-morbid-type-2-diabetes-mellitus-and-or-obstructive-sleep-apnea-5157https://curecurrent.com/trials/parents-and-children-together-preventing-diabetes-pact-pd-5158https://curecurrent.com/trials/absorption-and-safety-with-sustained-use-of-relizorb-evaluation-assure-study-5159https://curecurrent.com/trials/piedmont-aging-cognition-exercise-study-2-5160https://curecurrent.com/trials/lifestyle-intervention-for-treatment-of-diabetes-5161https://curecurrent.com/trials/insulin-dosing-practices-in-persons-with-diabetes-on-multiple-daily-injections-5162https://curecurrent.com/trials/the-effect-of-exercise-on-hepatic-glucose-metabolism-5163https://curecurrent.com/trials/effect-of-bkr-013-on-average-daily-glucose-levels-5164https://curecurrent.com/trials/macronutrient-effects-on-alzheimer-s-disease-meal-2-5165https://curecurrent.com/trials/healthy-lifestyles-for-mentally-ill-people-who-have-experienced-weight-gain-from-their-antipsychotic-medications-2-5166https://curecurrent.com/trials/a-trial-comparing-continuous-glucose-monitoring-with-and-without-routine-blood-glucose-monitoring-in-adults-with-type-1-5167https://curecurrent.com/trials/closed-loop-insulin-delivery-in-children-less-than-7-years-of-age-5168https://curecurrent.com/trials/exenatide-study-of-cardiovascular-event-lowering-trial-exscel-a-trial-to-evaluate-cardiovascular-outcomes-after-treatmen-5169https://curecurrent.com/trials/use-of-track-health-function-of-the-myhealthevet-personal-health-record-5170https://curecurrent.com/trials/randomized-trial-comparing-sitagliptin-to-placebo-in-closed-loop-5171https://curecurrent.com/trials/a-trial-of-incentives-and-peer-mentors-to-improve-diabetic-outcomes-5172https://curecurrent.com/trials/a-clinical-study-to-collect-calibration-performance-data-of-the-kbs-systems-1-0-non-invasive-glucose-monitoring-device-5173https://curecurrent.com/trials/user-study-for-enhanced-meter-feature-5174https://curecurrent.com/trials/pre-post-evaluation-of-temperature-steps-and-glucose-with-additional-time-spent-outdoors-in-an-urban-and-rural-setting-5175https://curecurrent.com/trials/mechanisms-of-weight-loss-with-sglt2-inhibition-5176https://curecurrent.com/trials/glycemic-effects-of-honey-5177https://curecurrent.com/trials/a-study-to-assess-the-safety-of-pf-06342674-in-adults-with-type-1-diabetes-5178https://curecurrent.com/trials/safety-study-to-examine-the-systemic-exposure-of-granexin-gel-after-topical-application-to-diabetic-foot-ulcers-5179https://curecurrent.com/trials/use-of-santyl-in-diabetic-foot-ulcers-5180https://curecurrent.com/trials/step-and-go-a-study-of-technology-based-exercise-promotion-5181https://curecurrent.com/trials/study-of-hdv-insulin-versus-insulin-in-type-1-diabetes-subjects-isle-1-5182https://curecurrent.com/trials/fatty-liver-study-in-patients-with-type-ii-diabetes-5183https://curecurrent.com/trials/comparison-of-hepatic-directed-vesicle-hdv-insulin-lispro-versus-insulin-lispro-to-further-improve-glycemic-control-5184https://curecurrent.com/trials/24-week-efficacy-and-safety-study-of-empagliflozin-bi-10773-in-hypertensive-black-african-american-patients-with-type-2-5185https://curecurrent.com/trials/21-day-comparison-of-continuous-insulin-infusion-using-hdv-insulin-to-standard-insulin-in-type-1-diabetes-mellitus-5186https://curecurrent.com/trials/immunogenicity-and-safety-study-of-glaxosmithkline-gsk-biologicals-engerix-b-in-adults-with-or-without-type-2-diabetes-m-5187https://curecurrent.com/trials/assessment-of-eyeart-as-an-automated-diabetic-retinopathy-screening-tool-5188https://curecurrent.com/trials/pilot-assessment-of-eyeart-as-an-automated-diabetic-retinopathy-screening-tool-5189https://curecurrent.com/trials/freestyle-libre-flash-glucose-monitoring-system-in-pediatric-populations-5190https://curecurrent.com/trials/a-study-of-multiple-doses-of-ly2922470-in-participants-with-diabetes-5191https://curecurrent.com/trials/effectiveness-study-of-pramlintide-to-treat-post-transplant-diabetes-mellitus-5192https://curecurrent.com/trials/evaluating-how-the-treatments-in-the-action-to-control-cardiovascular-risk-in-diabetes-accord-study-affect-diabetic-reti-5193https://curecurrent.com/trials/feasibility-study-of-retinal-screening-using-the-retinavue-100-camera-in-outpatient-dialysis-centers-5194https://curecurrent.com/trials/a-study-of-ly2409021-on-blood-pressure-and-pulse-rate-in-participants-with-type-2-diabetes-mellitus-5195https://curecurrent.com/trials/efficacy-of-oral-antibiotic-therapy-compared-to-intravenous-antibiotic-therapy-for-osteomyelitis-5196https://curecurrent.com/trials/detemir-role-in-type-1-diabetes-5197https://curecurrent.com/trials/metformin-and-congenital-nephrogenic-diabetes-insipidus-5198https://curecurrent.com/trials/a-follow-on-trial-to-assess-the-long-term-safety-and-efficacy-of-spm-927-in-painful-distal-diabetic-neuropathy-5199https://curecurrent.com/trials/use-of-insulin-glargine-to-treat-diabetic-ketoacidosis-5200https://curecurrent.com/trials/sglt2-inhibition-in-diabetes-and-heart-failure-5201https://curecurrent.com/trials/sitagliptin-dose-determination-study-5202https://curecurrent.com/trials/feasibility-evaluation-of-an-artificial-pancreas-with-glucose-prediction-trust-index-5203https://curecurrent.com/trials/taking-on-diabetes-to-advance-you-today-5204https://curecurrent.com/trials/a-study-of-single-and-multiple-doses-of-oral-insulin-or-placebo-in-subjects-with-type-2-diabetes-mellitus-5205https://curecurrent.com/trials/feasibility-study-using-run-to-run-control-to-optimize-continuous-glucose-sensor-bias-5206https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-cyclo-z-in-patients-with-obese-type-2-diabetes-5207https://curecurrent.com/trials/tracking-neurodegeneration-in-early-wolfram-syndrome-5208https://curecurrent.com/trials/pharmacist-led-group-medical-visits-to-help-with-diabetes-management-5209https://curecurrent.com/trials/t1dm-immunotherapy-using-cd4-cd127lo-cd25-polyclonal-tregs-5210https://curecurrent.com/trials/retinavue-diabetic-screening-5211https://curecurrent.com/trials/post-meal-insulin-dosing-with-adjuvant-pre-meal-pramlintide-in-children-with-type-1-diabetes-mellitus-5212https://curecurrent.com/trials/oxytocin-and-arginine-vasopressin-in-pain-relief-5213https://curecurrent.com/trials/effects-of-antidiabetic-medications-on-the-postprandial-state-in-prediabetes-5214https://curecurrent.com/trials/hybrid-closed-loop-hotel-studies-with-medtronic-pid-controller-5215https://curecurrent.com/trials/linagliptin-as-add-on-to-basal-insulin-in-the-elderly-5216https://curecurrent.com/trials/screening-brief-intervention-and-referral-to-treatment-in-primary-care-5217https://curecurrent.com/trials/efficacy-and-safety-of-exenatide-once-weekly-suspension-in-subjects-with-type-2-diabetes-5218https://curecurrent.com/trials/a-study-in-patients-with-type-2-diabetes-mellitus-5219https://curecurrent.com/trials/sleep-coping-and-executive-functioning-in-youth-with-type-1-diabetes-5220https://curecurrent.com/trials/frequency-of-blood-glucose-monitoring-in-patients-with-gestational-diabetes-5221https://curecurrent.com/trials/study-to-determine-if-different-prosthetic-sockets-effect-how-much-oxygen-is-in-the-tissue-of-lower-limb-amputees-while-5222https://curecurrent.com/trials/a-proposed-study-of-atherosclerotic-plaques-in-leg-arteries-5223https://curecurrent.com/trials/use-of-subtle-vibration-to-improve-walking-ability-by-lower-limb-amputees-5224https://curecurrent.com/trials/balancing-treatment-outcomes-and-medication-burden-among-patients-with-symptomatic-diabetic-peripheral-neuropathy-5225https://curecurrent.com/trials/powerup-for-health-a-diabetes-prevention-program-for-men-5226https://curecurrent.com/trials/tissue-specific-metabolic-reprogramming-in-diabetic-complications-5227https://curecurrent.com/trials/comfort-and-antimicrobial-efficacy-of-chlorhexidine-vs-betadine-for-intravitreal-injections-5228https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-isis-gcgrrx-in-patients-with-type-2-diabetes-5229https://curecurrent.com/trials/randomized-control-trial-of-fluid-therapy-for-pediatric-diabetic-ketoacidosis-5230https://curecurrent.com/trials/prevention-of-cystic-fibrosis-diabetes-5231https://curecurrent.com/trials/an-outpatient-study-of-automated-blood-glucose-control-with-an-insulin-only-bionic-pancreas-5232https://curecurrent.com/trials/use-of-sitagliptin-for-stress-hyperglycemia-or-mild-diabetes-following-cardiac-surgery-5233https://curecurrent.com/trials/study-of-adrenalectomy-versus-observation-for-subclinical-hypercortisolism-5234https://curecurrent.com/trials/effect-of-bydureon-on-carotid-atherosclerosis-progression-in-type-2-diabetes-mellitus-5235https://curecurrent.com/trials/intravitreal-alfibercept-for-center-involved-dme-previously-managed-with-intravitreal-ranibizumab-5236https://curecurrent.com/trials/development-of-a-novel-anti-hyperglycemic-agent-5237https://curecurrent.com/trials/a-research-trial-of-aralast-in-new-onset-diabetes-retain-5238https://curecurrent.com/trials/function-of-implanted-glucose-sensor-2-5239https://curecurrent.com/trials/insulet-artificial-pancreas-evaluating-meal-performance-and-moderate-exercise-ide2-5240https://curecurrent.com/trials/osteomyelitis-procalcitonin-to-diagnose-and-monitor-osteomyelitis-5241https://curecurrent.com/trials/a-study-for-patients-with-type-2-diabetes-5242https://curecurrent.com/trials/incentives-cognitive-training-and-internet-therapy-for-teens-with-poorly-controlled-type-1-diabetes-5243https://curecurrent.com/trials/evaluation-of-the-accuracy-of-an-implanted-glucose-sensor-5244https://curecurrent.com/trials/evaluation-of-extended-infusion-set-wear-using-medtronic-extended-wear-sof-set-infusion-set-5245https://curecurrent.com/trials/lifestyle-changes-through-exercise-and-nutrition-5246https://curecurrent.com/trials/a-study-of-atrasentan-on-reducing-albuminuria-in-type-2-diabetic-nephropathy-treated-with-renin-angiotensin-system-inhib-5247https://curecurrent.com/trials/reversal-of-hypoglycemia-unawareness-using-continuous-glucose-monitoring-5248https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-saxagliptin-co-administered-with-dapagliflozin-in-combination-with-metformi-5249https://curecurrent.com/trials/bright-1-bodies-weight-management-program-5250https://curecurrent.com/trials/a-performance-evaluation-of-the-enlite-glucose-sensor-to-support-a-full-144-hours-6days-of-use-5251https://curecurrent.com/trials/effect-of-endoplasmic-reticulum-stress-on-metabolic-function-5252https://curecurrent.com/trials/the-role-of-cholinergic-signaling-for-mediating-the-effects-of-gip-and-or-xenin-25-on-insulin-secretion-5253https://curecurrent.com/trials/serum-vasopressin-levels-and-severe-hemorrhagic-shock-5254https://curecurrent.com/trials/effect-of-food-order-on-postprandial-glucose-excursions-in-pre-diabetes-5255https://curecurrent.com/trials/study-to-compare-efficacy-of-the-minimed-paradigm-real-time-system-vs-mdi-in-subjects-naive-to-insulin-pump-therapy-5256https://curecurrent.com/trials/exercise-activity-based-bolus-decisions-in-type-1-diabetes-5257https://curecurrent.com/trials/study-of-ac-201-in-patients-with-type-2-diabetes-mellitus-5258https://curecurrent.com/trials/dermagraft-r-for-the-treatment-of-patients-with-diabetic-foot-ulcers-5259https://curecurrent.com/trials/pivotal-trial-of-dermagraft-r-to-treat-diabetic-foot-ulcers-5260https://curecurrent.com/trials/accu-chek-connect-at-school-cats-pediatric-study-5261https://curecurrent.com/trials/effect-of-gain-on-closed-loop-insulin-5262https://curecurrent.com/trials/efficacy-and-safety-of-alirocumab-versus-placebo-on-top-of-maximally-tolerated-lipid-lowering-therapy-in-patients-with-h-5263https://curecurrent.com/trials/effects-of-fish-oils-on-inflammation-and-insulin-resistance-5264https://curecurrent.com/trials/ozurdex-for-diabetic-macular-edema-treated-with-pars-plana-vitrectomy-and-membrane-removal-opera-study-5265https://curecurrent.com/trials/safety-and-efficacy-of-s-707106-in-subjects-with-type-2-diabetes-mellitus-and-inadequate-glycemic-control-with-metformin-5266https://curecurrent.com/trials/effects-of-lean-pork-high-protein-breakfast-on-satiety-and-metabolic-health-in-pre-diabetes-5267https://curecurrent.com/trials/addressing-diabetes-together-5268https://curecurrent.com/trials/epithelial-sodium-channel-enac-as-a-novel-mechanism-for-hypertension-and-volume-expansion-in-type-2-diabetes-5269https://curecurrent.com/trials/fat-metabolism-in-pregnancy-and-neonatal-heart-function-in-diabetes-5270https://curecurrent.com/trials/implementing-diabetes-group-visits-in-community-health-centers-5271https://curecurrent.com/trials/t-ir-study-to-understand-the-effects-of-testosterone-and-estrogen-on-the-body-s-response-to-the-hormone-insulin-5272https://curecurrent.com/trials/social-determinants-of-health-in-diabetes-outcomes-5273https://curecurrent.com/trials/the-effects-of-bethanechol-on-glucose-homeostasis-5274https://curecurrent.com/trials/feasibility-of-delivering-a-complex-behavioral-intervention-for-young-adults-with-diabetes-via-telehealth-5275https://curecurrent.com/trials/validation-of-insulin-protocol-for-glucocorticoid-induced-hyperglycemia-in-diabetic-oncology-patients-5276https://curecurrent.com/trials/international-diabetes-closed-loop-idcl-trial-research-site-training-protocol-5277https://curecurrent.com/trials/partnerships-to-improve-lifestyle-interventions-pili-ohana-dissemination-project-partners-in-care-5278https://curecurrent.com/trials/the-diabetic-foot-ulcer-registry-5279https://curecurrent.com/trials/quantitative-in-vivo-biomarkers-of-oxidative-stress-in-diabetes-5280https://curecurrent.com/trials/study-of-the-effects-of-xenin-25-in-humans-with-and-without-type-2-diabetes-mellitus-5281https://curecurrent.com/trials/a-study-to-compare-a-new-long-acting-insulin-ly2605541-and-human-insulin-nph-in-participants-with-type-2-diabetes-5282https://curecurrent.com/trials/health-promoters-and-pharmacists-in-diabetes-team-management-5283https://curecurrent.com/trials/vitamin-d-deficiency-insulin-resistance-and-fgf-23-5284https://curecurrent.com/trials/efficacy-and-safety-of-alirocumab-versus-usual-care-on-top-of-maximally-tolerated-statin-therapy-in-patients-with-type-2-5285https://curecurrent.com/trials/evaluating-the-feasibility-of-using-m-health-to-improve-serum-glucose-logs-5286https://curecurrent.com/trials/cellular-and-tissue-based-therapy-registry-5287https://curecurrent.com/trials/negative-pressure-wound-therapy-registry-5288https://curecurrent.com/trials/dose-ranging-study-to-evaluate-the-glycemic-effects-safety-and-tolerability-of-metformin-delayed-release-in-subjects-wit-5289https://curecurrent.com/trials/intervening-in-diabetes-with-healthy-eating-activity-and-linkages-to-healthcare-the-i-d-health-study-5290https://curecurrent.com/trials/characteristics-of-patients-with-type-2-diabetes-mellitus-receiving-treatment-with-dapagliflozin-versus-sitagliptin-an-a-5291https://curecurrent.com/trials/study-to-assess-safety-and-pharmacokinetics-of-double-blind-s-707106-alone-and-in-combination-with-open-label-metformin-5292https://curecurrent.com/trials/improving-diabetes-outcomes-with-activity-nutrition-and-medication-5293https://curecurrent.com/trials/study-to-compare-pharmacokinetics-pharmacodynamics-of-warfarin-esmolol-in-the-absence-presence-of-medi0382-5294https://curecurrent.com/trials/maternal-adipose-tissue-and-placental-dysfunction-programs-the-fetus-for-type-2-diabetes-placenta-dm-5295https://curecurrent.com/trials/a-study-for-participants-with-type-2-diabetes-mellitus-5296https://curecurrent.com/trials/a-study-of-ly2409021-in-patients-with-type-2-diabetes-5297https://curecurrent.com/trials/genetic-risk-and-health-coaching-for-type-2-diabetes-and-coronary-heart-disease-5298https://curecurrent.com/trials/mad-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-pb-119-to-subjects-with-t2dm-5299https://curecurrent.com/trials/a-study-of-ly2605541-in-participants-with-type-2-diabetes-mellitus-5300https://curecurrent.com/trials/a-study-of-ly2605541-in-participants-with-type-1-diabetes-mellitus-5301https://curecurrent.com/trials/a-mobile-phone-based-program-for-adults-with-prediabetes-5302https://curecurrent.com/trials/study-in-postmenopausal-women-with-type-2-diabetes-looking-at-approved-diabetes-drugs-and-how-they-affect-bone-health-5303https://curecurrent.com/trials/role-of-pregnancy-related-hormones-in-lowering-the-insulin-requirement-in-pregnant-women-with-type-1-diabetes-5304https://curecurrent.com/trials/comparator-trial-using-insulin-glulisine-vs-insulin-lispro-for-treatment-of-gestational-diabetes-5305https://curecurrent.com/trials/a-study-in-participants-with-type-2-diabetes-mellitus-5306https://curecurrent.com/trials/a-study-in-participants-with-type-i-diabetes-mellitus-5307https://curecurrent.com/trials/a-study-in-participants-with-type-1-diabetes-mellitus-5308https://curecurrent.com/trials/a-study-for-patients-with-type-1-diabetes-5309https://curecurrent.com/trials/sequencing-t-cells-in-type-i-diabetes-mellitus-5310https://curecurrent.com/trials/a-study-in-patients-with-type-2-diabetes-mellitus-5311https://curecurrent.com/trials/use-of-exenatide-and-pramlintide-to-decrease-post-prandial-hyperglycemia-5312https://curecurrent.com/trials/use-of-levemir-improves-metabolic-and-clinical-status-in-cystic-fibrosis-related-diabetes-cfrd-5313https://curecurrent.com/trials/salivary-transcriptome-biomarkers-for-early-diabetes-detection-5314https://curecurrent.com/trials/study-to-assess-the-safety-tolerability-pk-and-pd-response-of-pe0139-injection-in-adult-subjects-with-t2dm-5315https://curecurrent.com/trials/dose-escalation-study-to-evaluate-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-remd-477-in-subjects-with-5316https://curecurrent.com/trials/glucose-to-goal-a-model-to-support-diabetes-management-in-primary-care-5317https://curecurrent.com/trials/diabetes-prp-and-oct-5318https://curecurrent.com/trials/hemofiltration-in-burns-rescue-randomized-controlled-evaluation-of-hemofiltration-in-adult-burn-patients-with-septic-sho-5319https://curecurrent.com/trials/pilot-study-of-oct-versus-fluorescein-angiography-in-dme-5320https://curecurrent.com/trials/diabetes-self-management-support-live-5321https://curecurrent.com/trials/pk-pd-study-with-g-pump-glucagon-infusion-in-t1dm-patients-5322https://curecurrent.com/trials/cardia-brain-mri-substudy-5323https://curecurrent.com/trials/a-study-evaluating-the-effect-of-albiglutide-on-gallbladder-emptying-in-healthy-subjects-5324https://curecurrent.com/trials/longitudinal-study-in-perimenopausal-women-with-risk-factors-for-atherosclerosis-5325https://curecurrent.com/trials/foundations-for-health-5326https://curecurrent.com/trials/boosting-emotions-happiness-in-outpatients-living-with-diabetes-phase-i-5327https://curecurrent.com/trials/a-study-of-the-function-of-hormones-present-in-taste-buds-5328https://curecurrent.com/trials/safety-and-efficacy-study-of-mini-dose-glucagon-g-pen-mini-in-patients-with-type-1-diabetes-5329https://curecurrent.com/trials/development-of-self-regulation-in-individuals-with-type-2-diabetes-5330https://curecurrent.com/trials/fat-grafting-for-pedal-fat-pad-atrophy-in-diabetics-5331https://curecurrent.com/trials/antihypertensive-medication-exposure-as-risk-for-impaired-glucose-tolerance-a-pear-sub-study-5332https://curecurrent.com/trials/ghrelin-and-beta-cell-function-in-diabetes-5333https://curecurrent.com/trials/a-26-week-trial-comparing-efficacy-and-safety-of-insulin-degludec-insulin-aspart-bid-and-insulin-degludec-od-plus-insuli-5334https://curecurrent.com/trials/comparison-of-the-efficacy-and-safety-of-two-different-dose-adjustment-regimens-for-insulin-degludec-insulin-aspart-in-s-5335https://curecurrent.com/trials/preferred-treatment-of-type-1-5-diabetes-5336https://curecurrent.com/trials/a-clinical-trial-comparing-efficacy-and-safety-of-insulin-degludec-liraglutide-ideglira-versus-basal-bolus-therapy-in-su-5337https://curecurrent.com/trials/subanalyses-of-elderly-type-2-diabetes-patients-or-type-2-diabetes-patients-with-renal-impairment-5338https://curecurrent.com/trials/primary-care-community-partnerships-to-prevent-diabetes-5339https://curecurrent.com/trials/personalized-smartphone-assisted-coaching-system-to-improve-glucose-homeostasis-in-adults-with-prediabetes-5340https://curecurrent.com/trials/prospective-assessment-in-newborns-for-diabetes-autoimmunity-5341https://curecurrent.com/trials/golo-open-label-pilot-1-5342https://curecurrent.com/trials/effect-of-sulodexide-in-early-diabetic-nephropathy-5343https://curecurrent.com/trials/insulin-detemir-compared-to-insulin-glargine-appetite-and-calories-consumed-in-type-1-diabetes-5344https://curecurrent.com/trials/a-couples-based-approach-for-increasing-physical-activity-among-adults-with-type-2-diabetes-5345https://curecurrent.com/trials/efficacy-and-safety-study-of-rosiglitazone-metformin-therapy-vs-rosiglitazone-and-metformin-in-type-2-diabetes-subjects-5346https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-an-investigational-diabetes-drug-in-poorly-controlled-type-ii-diabetics-5347https://curecurrent.com/trials/a-new-oral-treatment-for-type-ii-diabetes-mellitus-5348https://curecurrent.com/trials/ed-management-of-severe-hyperglycemia-a-clinical-trial-5349https://curecurrent.com/trials/whole-grains-gastric-emptying-and-glycemic-response-5350https://curecurrent.com/trials/improving-risk-factors-for-diabetes-complications-in-primary-care-5351https://curecurrent.com/trials/comparison-of-time-restricted-feeding-versus-grazing-5352https://curecurrent.com/trials/a-study-of-an-automated-insulin-delivery-system-in-participants-with-type-1-diabetes-mellitus-t1dm-5353https://curecurrent.com/trials/high-risk-obstetrical-patient-intervention-utilizing-the-contraceptive-choice-project-script-5354https://curecurrent.com/trials/dermacell-in-subjects-with-chronic-wounds-of-the-lower-extremities-5355https://curecurrent.com/trials/parental-management-of-young-children-s-diabetes-5356https://curecurrent.com/trials/increased-gluconeogenesis-is-one-cause-of-cystic-fibrosis-related-diabetes-cfrd-5357https://curecurrent.com/trials/a-complex-contraception-registry-5358https://curecurrent.com/trials/home-testing-of-day-and-night-closed-loop-with-pump-suspend-feature-5359https://curecurrent.com/trials/a-study-to-assess-the-bioequivalence-of-dapagliflozin-metformin-xr-fixed-dose-combination-tablets-in-healthy-subjects-5360https://curecurrent.com/trials/brief-cbt-interventions-delivered-by-nurse-care-managers-to-improve-type-2-diabetes-outcomes-pilot-study-5361https://curecurrent.com/trials/effect-of-sitagliptin-on-short-term-metabolic-dysregulation-of-oral-glucocorticoid-therapy-5362https://curecurrent.com/trials/opt2mise-glucose-control-in-type-2-diabetes-mellitus-dm-with-insulin-pump-therapy-5363https://curecurrent.com/trials/evaluate-the-efficacy-of-insulin-patients-with-type-1-diabetes-5364https://curecurrent.com/trials/study-of-human-insulin-inhalation-powder-in-patients-with-type-1-diabetes-5365https://curecurrent.com/trials/compare-two-dosing-algorithms-in-insulin-naive-patients-with-type-2-diabetes-mellitus-5366https://curecurrent.com/trials/evaluate-the-efficacy-and-safety-of-insulin-compared-to-glargine-in-patients-with-type-2-diabetes-5367https://curecurrent.com/trials/mechanisms-of-diabetes-control-after-weight-loss-surgery-5368https://curecurrent.com/trials/drugs-for-high-blood-pressure-and-high-cholesterol-in-american-indians-with-type-2-diabetes-5369https://curecurrent.com/trials/testing-state-of-the-art-remote-glucose-monitoring-at-diabetes-camp-5370https://curecurrent.com/trials/insulin-resistance-and-insulin-secretion-5371https://curecurrent.com/trials/diabetes-prevention-program-5372https://curecurrent.com/trials/the-diabetes-telecare-study-5373https://curecurrent.com/trials/effects-of-resveratrol-on-endothelial-function-in-type-2-diabetes-mellitus-5374https://curecurrent.com/trials/new-ways-to-help-patients-improve-their-diabetes-control-5375https://curecurrent.com/trials/dose-dependent-effects-of-erythritol-on-endothelial-function-in-type-2-diabetes-mellitus-5376https://curecurrent.com/trials/development-of-algorithms-for-a-hypoglycemic-prevention-alarm-closed-loop-study-5377https://curecurrent.com/trials/dose-comparisons-of-leucine-metformin-combinations-on-blood-glucose-levels-in-type-2-diabetic-patients-5378https://curecurrent.com/trials/using-a-motivational-interviewing-mi-informed-text-messaging-program-to-lower-blood-sugar-in-diabetic-patients-5379https://curecurrent.com/trials/polyunsaturated-fatty-acids-pufa-in-diabetic-fatty-liver-5380https://curecurrent.com/trials/a-pilot-clinical-trial-of-exendin-4-in-alzheimer-s-disease-5381https://curecurrent.com/trials/uncovering-the-origins-of-diabetes-5382https://curecurrent.com/trials/effectiveness-and-safety-study-of-the-abbott-sensor-based-glucose-monitoring-systems-5383https://curecurrent.com/trials/optimizing-behavioral-health-homes-for-adults-with-serious-mental-illness-5384https://curecurrent.com/trials/closed-loop-system-with-pramlintide-versus-exenatide-5385https://curecurrent.com/trials/video-games-for-obesity-and-diabetes-prevention-diab-nano-5386https://curecurrent.com/trials/effects-of-dietary-supplement-tauroursodeoxycholic-acid-on-vascular-function-5387https://curecurrent.com/trials/dual-action-of-liraglutide-and-insulin-degludec-in-type-2-diabetes-a-trial-comparing-the-efficacy-and-safety-of-insulin-5388https://curecurrent.com/trials/study-comparing-versajet-with-conventional-surgical-procedures-in-the-removal-of-unhealthy-tissue-from-lower-limb-ulcers-5389https://curecurrent.com/trials/the-study-of-inflammation-on-blood-glucose-levels-in-obese-people-5390https://curecurrent.com/trials/vasopressin-administration-during-laparoscopic-myomectomy-a-randomized-controlled-trial-5391https://curecurrent.com/trials/smart-technology-for-weight-loss-and-metabolic-health-5392https://curecurrent.com/trials/bnp-pharmacodynamics-and-effects-on-metabolism-in-lean-and-obese-subjects-5393https://curecurrent.com/trials/stories-for-change-digital-storytelling-as-a-tool-for-engagement-in-facilitated-discussion-for-diabetes-5394https://curecurrent.com/trials/a-pilot-study-investigating-bioequivalence-between-a-single-dose-of-formulation-2-and-formulation-3-of-medi0382-5395https://curecurrent.com/trials/safety-and-efficacy-of-incb013739-plus-metformin-compared-to-metformin-alone-on-glycemic-control-in-type-2-diabetics-5396https://curecurrent.com/trials/improving-medication-safety-and-cvd-risk-factor-control-in-kidney-transplant-recipients-5397https://curecurrent.com/trials/effects-of-branch-chain-amino-acids-on-glucose-tolerance-in-obese-pre-diabetic-subjects-5398https://curecurrent.com/trials/pharmacologic-treatment-of-congenital-nephrogenic-diabetes-insipidus-5399https://curecurrent.com/trials/single-dose-and-multiple-dose-safety-and-tolerability-study-of-pf-04856883-in-type-2-diabetic-adult-females-5400https://curecurrent.com/trials/study-of-the-effectiveness-and-safety-of-sugardown-vs-placebo-in-type-2-diabetic-subjects-treated-with-metformin-5401https://curecurrent.com/trials/comparing-google-with-a-focused-diabetes-search-engine-5402https://curecurrent.com/trials/combinatorial-therapy-for-peristent-type-2-diabetes-after-gastric-banding-5403https://curecurrent.com/trials/prandial-insulin-dosing-in-hospitalized-patients-5404https://curecurrent.com/trials/controlling-hyperglycemia-among-minority-population-5405https://curecurrent.com/trials/a-comparison-of-the-checkup-vision-assessment-system-to-standard-vision-assessment-tools-5406https://curecurrent.com/trials/effects-of-mifepristone-on-biomarkers-of-metabolic-function-and-neuropsychological-performance-among-middle-aged-and-old-5407https://curecurrent.com/trials/evaluating-the-influence-of-diabetes-stigma-on-medication-adherence-5408https://curecurrent.com/trials/effectiveness-of-aurix-therapy-in-diabetic-foot-ulcers-5409https://curecurrent.com/trials/sitagliptin-metformin-compared-to-metformin-monotherapy-and-placebo-in-women-with-a-recent-gdm-5410https://curecurrent.com/trials/egg-intake-and-risk-of-type-2-diabetes-5411https://curecurrent.com/trials/cocoa-polyphenols-and-postprandial-metabolism-in-type-2-diabetes-5412https://curecurrent.com/trials/effect-of-liraglutide-on-body-weight-in-non-diabetic-obese-subjects-or-overweight-subjects-with-co-morbidities-scale-obe-5413https://curecurrent.com/trials/comparison-of-sar342434-to-humalog-as-the-rapid-acting-insulin-in-adult-patients-with-type-1-diabetes-mellitus-also-usin-5414https://curecurrent.com/trials/multi-channel-automated-diet-and-physical-activity-intervention-for-pre-diabetics-5415https://curecurrent.com/trials/safety-and-efficacy-of-biphasic-remogliflozin-etabonate-in-the-treatment-of-type-2-diabetes-5416https://curecurrent.com/trials/raspberries-and-postprandial-metabolism-5417https://curecurrent.com/trials/study-to-investigate-the-pathophysiology-of-type-2-diabetes-in-youth-5418https://curecurrent.com/trials/comparison-of-sar342434-to-humalog-as-the-rapid-acting-insulin-in-adult-patients-with-type-2-diabetes-mellitus-also-usin-5419https://curecurrent.com/trials/effect-of-pioglitazone-and-exenatide-on-body-weight-and-beta-cell-function-5420https://curecurrent.com/trials/restoration-of-retinal-vascular-responses-in-type-1-diabetic-patients-5421https://curecurrent.com/trials/measurement-of-glucose-metabolism-in-humans-using-magnetic-resonance-at-4-tesla-substudy-hypoglycemia-unawareness-5422https://curecurrent.com/trials/a-study-in-type-2-diabetics-of-single-and-multiple-doses-of-orally-administered-gsk1292263-to-investigate-the-safety-tol-5423https://curecurrent.com/trials/an-extension-protocol-to-evaluate-dose-comparisons-of-leucine-metformin-combinations-in-type-2-diabetic-patients-5424https://curecurrent.com/trials/abate-follow-up-study-5425https://curecurrent.com/trials/effect-of-a-medium-chain-triglyceride-supplemented-diet-on-cognitive-function-and-brain-activation-in-type-1-diabetes-5426https://curecurrent.com/trials/registry-trial-of-the-effectiveness-of-platelet-rich-plasma-for-chronic-non-healing-wounds-5427https://curecurrent.com/trials/adding-liraglutide-to-high-dose-insulin-breaking-the-cycle-5428https://curecurrent.com/trials/an-inpatient-performance-evaluation-of-a-new-subcutaneous-glucose-sensor-5429https://curecurrent.com/trials/epigenetics-and-the-origin-of-muscle-insulin-resistance-in-humans-5430https://curecurrent.com/trials/nociceptive-pain-fiber-response-5431https://curecurrent.com/trials/a-study-of-lgd-6972-in-patients-with-type-2-diabetes-mellitus-5432https://curecurrent.com/trials/freestyle-libre-flash-accuracy-study-5433https://curecurrent.com/trials/the-effect-of-exenatide-compared-to-lantus-insulin-on-vascular-function-in-type-2-diabetes-5434https://curecurrent.com/trials/dts-blood-glucose-monitor-system-surveillance-program-substudy-1-5435https://curecurrent.com/trials/cbt-for-adherence-and-depression-in-diabetes-5436https://curecurrent.com/trials/utilizing-off-the-shelf-technology-to-improve-diabetes-management-in-a-rural-population-5437https://curecurrent.com/trials/diabetes-group-prenatal-care-5438https://curecurrent.com/trials/treatment-differences-between-canagliflozin-and-placebo-in-insulin-secretion-in-subjects-with-type-2-diabetes-mellitus-t-5439https://curecurrent.com/trials/comparative-study-of-implant-surfaces-to-enhance-stabilization-in-patients-with-type-2-diabetes-5440https://curecurrent.com/trials/heart-rate-variability-in-response-to-metformin-challenge-5441https://curecurrent.com/trials/point-of-care-glucose-testing-and-insulin-supplementation-5442https://curecurrent.com/trials/intensive-glycemic-control-for-congestive-heart-failure-exacerbation-5443https://curecurrent.com/trials/effect-of-liraglutide-on-body-weight-in-overweight-or-obese-subjects-with-type-2-diabetes-scale-diabetes-5444https://curecurrent.com/trials/tau-pet-imaging-in-northern-manhattan-study-of-metabolism-and-mind-5445https://curecurrent.com/trials/omega-3-fa-supplements-as-augmentation-in-the-treatment-of-depression-5446https://curecurrent.com/trials/role-of-pancreatic-triglyceride-content-in-beta-cell-function-5447https://curecurrent.com/trials/oct-screening-for-diabetic-macular-edema-at-primary-diabetes-care-visits-5448https://curecurrent.com/trials/comparing-strategies-for-translating-self-management-support-into-primary-care-5449https://curecurrent.com/trials/economic-outcomes-of-eqw-exenatide-once-weekly-vs-ig-insulin-glargine-in-t2d-patients-who-are-new-to-injectable-therapy-5450https://curecurrent.com/trials/impact-of-patient-activation-and-engagement-on-patient-centered-outcomes-of-care-in-acos-5451https://curecurrent.com/trials/role-of-slowly-digesible-starch-on-diabetes-risk-factors-5452https://curecurrent.com/trials/the-metabolic-effects-of-short-term-walnut-consumption-in-subjects-with-the-metabolic-syndrome-5453https://curecurrent.com/trials/preservation-of-beta-cell-function-in-type-2-diabetes-mellitus-5454https://curecurrent.com/trials/three-approaches-to-glucose-monitoring-in-non-insulin-treated-diabetes-5455https://curecurrent.com/trials/changes-in-ectopic-fat-following-surgically-induced-weight-loss-5456https://curecurrent.com/trials/to-investigate-the-safety-tolerability-and-pharmacodynamics-of-gsk2890457-in-healthy-volunteers-and-subjects-with-type-2-5457https://curecurrent.com/trials/pioglitazone-on-pancreatic-steatosis-and-bone-health-5458https://curecurrent.com/trials/open-label-study-in-diabetic-foot-ulcers-dfu-to-evaluate-safety-of-0-03-dsc127-topical-gel-in-chronic-use-5459https://curecurrent.com/trials/effect-of-closed-loop-glucose-control-on-exercise-associated-hypoglycemia-5460https://curecurrent.com/trials/inpatient-closed-loop-glucose-control-5461https://curecurrent.com/trials/treatment-of-diabetes-and-depression-in-hispanics-and-african-americans-and-its-effect-on-a1c-and-quality-of-life-5462https://curecurrent.com/trials/phase-iii-study-to-evaluate-efficacy-and-safety-of-dsc127-in-diabetic-foot-ulcers-5463https://curecurrent.com/trials/phase-3-study-evaluating-efficacy-and-safety-of-dsc127-compared-with-vehicle-and-with-standard-of-care-in-diabetic-foot-5464https://curecurrent.com/trials/the-relationship-of-hemoglobin-a1c-and-diabetic-wound-healing-5465https://curecurrent.com/trials/vitamin-d-supplementation-on-cardiovascular-risk-factors-5466https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-camicinal-on-gastroparesis-symptoms-in-type-1-and-2-diabetic-subjects-with-gastropares-5467https://curecurrent.com/trials/targeting-inflammation-using-salsalate-for-type-2-diabetes-stage-ii-5468https://curecurrent.com/trials/pioglitazone-as-a-treatment-for-lipid-and-glucose-abnormalities-in-patients-with-schizophrenia-5469https://curecurrent.com/trials/ticagrelor-versus-clopidogrel-in-type-2-diabetic-patients-5470https://curecurrent.com/trials/evaluation-of-the-gestational-diabetes-self-management-education-program-and-quality-improvement-plan-5471https://curecurrent.com/trials/randomized-trial-to-evaluate-the-effectiveness-of-nurse-case-management-5472https://curecurrent.com/trials/dose-ranging-study-in-treatment-naive-type-2-diabetes-mellitus-t2dm-5473https://curecurrent.com/trials/direct-renin-inhibition-effects-on-atherosclerotic-biomarkers-5474https://curecurrent.com/trials/phase-iv-study-to-evaluate-the-efficacy-of-amnioexcel-in-diabetic-foot-ulcers-5475https://curecurrent.com/trials/a-study-with-primatrix-dermal-repair-scaffold-for-the-treatment-of-diabetic-foot-ulcers-5476https://curecurrent.com/trials/dss-diabetes-surgery-study-intensive-medical-management-of-type-2-diabetes-with-and-without-gastric-bypass-surgery-5477https://curecurrent.com/trials/study-of-islet-transplantation-in-type-1-diabetic-kidney-transplant-recipients-5478https://curecurrent.com/trials/diabetes-study-with-rosiglitazone-monotherapy-versus-metformin-or-glyburide-glibenclamide-5479https://curecurrent.com/trials/norepinephrine-and-vasopressin-versus-norepinephrine-alone-in-critically-ill-patients-with-septic-shock-5480https://curecurrent.com/trials/molecular-regulation-of-muscle-glucose-metabolism-5481https://curecurrent.com/trials/real-time-continuous-glucose-monitoring-5482https://curecurrent.com/trials/acute-effect-of-exenatide-on-brain-glucose-metabolism-5483https://curecurrent.com/trials/safety-and-effects-of-autologous-adipose-derived-stromal-cells-delivered-in-patients-with-type-ii-diabetes-5484https://curecurrent.com/trials/a-multicenter-study-of-outpatient-automated-blood-glucose-control-with-a-bihormonal-bionic-pancreas-5485https://curecurrent.com/trials/cardiovascular-outcomes-in-participants-with-type-2-diabetes-mellitus-t2dm-5486https://curecurrent.com/trials/is-a-smartphone-application-effective-as-an-oral-medication-adherence-aid-5487https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pk-and-pd-of-da-1241-in-healthy-male-subjects-5488https://curecurrent.com/trials/exercise-to-reduce-obesity-in-spinal-cord-injury-5489https://curecurrent.com/trials/effects-of-web-based-health-information-on-risk-behavior-for-youth-with-type-1-diabetes-in-college-5490https://curecurrent.com/trials/integration-of-continuous-glucose-monitoring-into-a-bihormonal-closed-loop-artificial-pancreas-5491https://curecurrent.com/trials/a-phase-1-study-to-evaluate-hti-2088-tablet-5492https://curecurrent.com/trials/trx4-monoclonal-antibody-in-type-1-diabetes-t1-dm-5493https://curecurrent.com/trials/extended-follow-up-after-islet-transplantation-in-t1d-5494https://curecurrent.com/trials/simplified-insulin-protocol-using-lantus-in-elderly-5495https://curecurrent.com/trials/protein-amino-acids-insulin-glucagon-secretion-in-humans-5496https://curecurrent.com/trials/feasibility-and-efficacy-of-delivering-blood-glucose-awareness-training-over-the-internet-5497https://curecurrent.com/trials/biospecimens-for-identification-of-diseases-of-the-pancreas-5498https://curecurrent.com/trials/obstructive-sleep-apnea-osa-sleepiness-and-activity-in-diabetes-management-5499https://curecurrent.com/trials/a-first-in-human-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-hm12460a-5500https://curecurrent.com/trials/diabetic-shoulder-mobility-5501https://curecurrent.com/trials/relationship-between-hba1c-and-chronic-glycemia-in-patients-with-cirrhosis-5502https://curecurrent.com/trials/effect-of-weight-bearing-exercise-on-people-with-diabetes-and-neuropathic-feet-5503https://curecurrent.com/trials/risk-assessment-of-long-haul-truck-drivers-5504https://curecurrent.com/trials/an-evaluation-of-an-sccd-on-the-symptomatology-of-painful-dpn-5505https://curecurrent.com/trials/vasopressin-effects-on-human-social-communication-5506https://curecurrent.com/trials/egg-ingestion-in-adults-with-type-2-diabetes-5507https://curecurrent.com/trials/a-study-investigating-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-gsk2330672-administered-with-metformi-5508https://curecurrent.com/trials/multiple-ascending-dose-study-of-hm12470-in-type-1-and-type-2-diabetes-mellitus-5509https://curecurrent.com/trials/accu-chek-connect-personal-diabetes-management-study-pdm-connect-5510https://curecurrent.com/trials/behavioral-activation-therapy-for-rural-veterans-with-diabetes-and-depression-5511https://curecurrent.com/trials/a-trial-evaluating-compatibility-and-safety-of-fiasp-and-insulin-aspart-with-an-external-continuous-subcutaneous-insulin-5512https://curecurrent.com/trials/dose-ranging-study-in-subjects-with-type-2-diabetes-mellitus-who-are-treatment-naive-5513https://curecurrent.com/trials/molecular-regulation-of-muscle-glucose-metabolism-aims-2a-2b-3-5514https://curecurrent.com/trials/the-efficacy-of-insulin-degludec-liraglutide-as-add-on-therapy-in-controlling-glycaemia-in-adults-with-type-2-diabetes-i-5515https://curecurrent.com/trials/pgc-1-muscle-mitochondrial-dysfunction-in-diabetes-aims-1-4-5516https://curecurrent.com/trials/wine-consumption-and-glycemic-control-5517https://curecurrent.com/trials/closed-loop-glucose-control-for-automated-management-of-type-1-diabetes-5518https://curecurrent.com/trials/raptiva-and-sirolimus-in-islet-transplantation-for-type-1-diabetes-5519https://curecurrent.com/trials/enhancing-informal-caregiving-to-support-diabetes-self-management-5520https://curecurrent.com/trials/diabetic-ketoacidosis-brain-morphology-and-cognition-5521https://curecurrent.com/trials/a-study-of-ly2963016-compared-to-lantus-in-adult-participants-with-type-2-diabetes-mellitus-5522https://curecurrent.com/trials/effects-of-kdt501-on-metabolic-features-in-insulin-resistant-subjects-5523https://curecurrent.com/trials/efficacy-of-islet-after-kidney-transplantation-5524https://curecurrent.com/trials/the-summer-camp-study-2-blood-glucose-control-with-a-bi-hormonal-endocrine-pancreas-5525https://curecurrent.com/trials/improving-outcomes-in-underserved-women-with-gdm-5526https://curecurrent.com/trials/effects-of-continuous-positive-airway-pressure-cpap-on-glucose-metabolism-5527https://curecurrent.com/trials/family-weight-management-study-5528https://curecurrent.com/trials/dream-project-community-health-worker-intervention-5529https://curecurrent.com/trials/fatty-acid-metabolism-and-insulin-sensitivity-the-role-of-endurance-exercise-5530https://curecurrent.com/trials/a-study-in-type-2-diabetic-subjects-on-stable-metformin-therapy-to-investigate-the-safety-tolerability-pharmacokinetics-5531https://curecurrent.com/trials/efficacy-and-safety-of-artacent-for-treatment-resistant-lower-extremity-venous-and-diabetic-ulcers-5532https://curecurrent.com/trials/call-2-health-preventing-type-ii-diabetes-5533https://curecurrent.com/trials/effects-of-canagliflozin-on-intravascular-volume-and-hemodynamics-5534https://curecurrent.com/trials/differential-metabolism-of-dietary-fatty-acids-5535https://curecurrent.com/trials/a-study-of-gsk256073-in-subjects-with-type-2-diabetes-mellitus-who-are-being-treated-with-metformin-5536https://curecurrent.com/trials/mobile-communication-technology-for-adolescents-with-diabetes-5537https://curecurrent.com/trials/a-study-to-assess-the-safety-of-single-doses-of-gsk189075-in-subjects-with-type-1-diabetes-mellitus-5538https://curecurrent.com/trials/magnetic-resonance-angiography-to-diagnose-atherosclerotic-disease-5539https://curecurrent.com/trials/immunosuppression-impact-on-the-metabolic-control-of-kidney-transplant-with-pre-existing-type-2-diabetes-dm-5540https://curecurrent.com/trials/evaluation-of-single-nucleotide-polymorphisms-snps-in-patients-with-and-without-diabetic-macular-edema-5541https://curecurrent.com/trials/impact-inactivity-monitoring-and-physical-activity-controlled-trial-5542https://curecurrent.com/trials/families-on-track-a-digital-health-behavioral-intervention-for-parents-seeking-treatment-for-their-child-with-obesity-5543https://curecurrent.com/trials/improving-outcomes-for-individuals-with-serious-mental-illness-and-diabetes-5544https://curecurrent.com/trials/trial-of-otelixizumab-for-adults-with-newly-diagnosed-type-1-diabetes-mellitus-autoimmune-defend-1-5545https://curecurrent.com/trials/evaluating-the-effect-of-aliskiren-versus-hctz-on-coronary-flow-reserve-in-hypertensive-type-ii-diabetics-5546https://curecurrent.com/trials/medtronic-treat-to-range-ttr-closed-loop-control-5547https://curecurrent.com/trials/comparison-of-neutral-protamine-hagedorn-nph-and-lantus-based-insulin-regimen-in-the-management-of-hypoglycemia-in-the-h-5548https://curecurrent.com/trials/in-clinic-evaluation-of-the-plgm-feature-5549https://curecurrent.com/trials/computer-based-intervention-for-type-2-diabetes-in-youth-5550https://curecurrent.com/trials/study-of-clonidine-hydrochloride-topical-gel-0-1-in-the-treatment-of-pain-associated-with-diabetic-neuropathy-5551https://curecurrent.com/trials/metformin-at-the-cellular-level-and-dosing-for-diabetes-mellitus-dm-5552https://curecurrent.com/trials/biological-basis-of-individual-variation-in-social-cooperation-5553https://curecurrent.com/trials/the-effect-of-insulin-degludec-in-combination-with-liraglutide-and-metformin-in-subjects-with-type-2-diabetes-qualifying-5554https://curecurrent.com/trials/circuit-training-and-motivational-interviewing-to-reduce-type-2-diabetes-in-youth-5555https://curecurrent.com/trials/pilot-study-assessing-insulin-pump-therapy-in-type-2-diabetes-5556https://curecurrent.com/trials/exhaled-carbon-monoxide-and-red-blood-cell-turnover-5557https://curecurrent.com/trials/the-efficacy-and-safety-of-clonidine-hydrochloride-topical-gel-vs-clonidine-hydrochloride-gel-comparator-to-treat-painfu-5558https://curecurrent.com/trials/a-safety-study-of-clonidine-hydrochloride-topical-gel-0-1-in-the-treatment-of-painful-diabetic-neuropathy-5559https://curecurrent.com/trials/computer-based-screening-for-diabetic-retinopathy-5560https://curecurrent.com/trials/combination-therapy-with-sitagliptin-and-lansoprazole-to-restore-pancreatic-beta-cell-function-in-recent-onset-type-1-di-5561https://curecurrent.com/trials/reducing-total-cardiovascular-risk-in-an-urban-community-5562https://curecurrent.com/trials/social-forces-to-improve-statin-adherence-study-a-5563https://curecurrent.com/trials/preservation-of-pancreatic-beta-cell-function-through-insulin-pump-therapy-5564https://curecurrent.com/trials/effects-of-statins-on-lower-extremity-arterial-function-assessed-by-magnetic-resonance-imaging-5565https://curecurrent.com/trials/medtronic-minimed-implantable-insulin-pump-5566https://curecurrent.com/trials/effect-of-gsk376501-on-cyp450-activity-in-healthy-adult-subjects-5567https://curecurrent.com/trials/healthy-io-method-comparison-user-performance-study-5568https://curecurrent.com/trials/injection-site-study-in-patients-with-type-2-diabetes-mellitus-t2dm-and-healthy-volunteers-5569https://curecurrent.com/trials/the-effect-of-exenatide-on-weight-and-hunger-in-obese-healthy-women-5570https://curecurrent.com/trials/the-summer-camp-study-blood-glucose-control-with-a-bi-hormonal-bionic-endocrine-pancreas-5571https://curecurrent.com/trials/first-time-in-humans-study-to-assess-safety-pharmacokinetics-pharmacodynamics-of-sb756050-5572https://curecurrent.com/trials/a-study-to-assess-the-safety-and-tolerability-of-gsk189075-when-given-with-a-total-daily-dose-of-2000mg-of-metformin-5573https://curecurrent.com/trials/freestyle-libre-flash-glucose-monitoring-system-accuracy-5574https://curecurrent.com/trials/egg-consumption-and-glycemic-control-in-individuals-with-pre-and-type-ii-diabetes-5575https://curecurrent.com/trials/calorie-restriction-and-changes-in-body-composition-disease-function-and-quality-of-life-in-older-adults-5576https://curecurrent.com/trials/metformin-s-effect-on-glucagon-induced-glucose-production-and-protein-metabolism-5577https://curecurrent.com/trials/metformin-for-weight-loss-in-schizophrenia-5578https://curecurrent.com/trials/effect-of-ethanol-intoxication-on-the-anti-hypoglycemic-action-of-glucagon-5579https://curecurrent.com/trials/schizophrenia-antipsychotic-treatment-and-the-risk-for-diabetes-mellitus-5580https://curecurrent.com/trials/evaluation-of-an-ascensia-blood-glucose-meter-and-app-system-5581https://curecurrent.com/trials/dhacm-mesh-in-the-treatment-of-diabetic-foot-ulcers-5582https://curecurrent.com/trials/encourage-healthy-families-5583https://curecurrent.com/trials/diabetes-prevention-translation-the-healthy-lifestyle-project-5584https://curecurrent.com/trials/families-preventing-diabetes-together-5585https://curecurrent.com/trials/a-study-to-assess-the-safety-of-repeated-doses-of-gsk189075-and-wellbutrin-sr-in-healthy-male-subjects-5586https://curecurrent.com/trials/effectiveness-and-safety-study-of-the-dexcom-g4-platinum-with-modified-algorithm-5587https://curecurrent.com/trials/advanced-medical-therapy-versus-advanced-medical-therapy-plus-bariatric-surgery-for-the-resolution-of-type-2-diabetes-5588https://curecurrent.com/trials/risk-of-diabetes-in-young-turner-syndrome-patients-5589https://curecurrent.com/trials/avastin-for-pdr-proliferative-diabetic-retinopathy-5590https://curecurrent.com/trials/pediatrics-owning-performance-study-5591https://curecurrent.com/trials/scintigraphy-study-to-assess-gastric-emptying-in-healthy-subjects-given-gsk716155-or-placebo-5592https://curecurrent.com/trials/study-to-investigate-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-gsk2330672-in-type-2-diabetes-patients-5593https://curecurrent.com/trials/a-study-to-evaluate-the-food-effect-on-drug-availability-pharmacokinetic-pk-properties-safety-and-tolerability-of-two-di-5594https://curecurrent.com/trials/diet-and-systemic-inflammation-5595https://curecurrent.com/trials/adverse-effects-of-systemic-hypoglycemia-exposure-on-endothelial-function-in-humans-5596https://curecurrent.com/trials/diabetes-scorecard-educational-intervention-study-5597https://curecurrent.com/trials/vasopressin-and-the-social-brain-5598https://curecurrent.com/trials/use-of-sitagliptin-to-decrease-microalbuminuria-5599https://curecurrent.com/trials/dose-effect-of-ssr180575-in-diabetic-neuropathy-5600https://curecurrent.com/trials/a-12-week-study-to-evaluate-pf-06291874-once-a-day-in-adults-with-t2dm-inadequately-controlled-on-metformin-5601https://curecurrent.com/trials/study-to-determine-the-utility-of-novel-technologies-and-biomarkers-to-measure-human-response-to-rosiglitazone-maleate-5602https://curecurrent.com/trials/active-and-healthy-brotherhood-a-program-for-chronic-disease-self-management-for-black-men-5603https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-in-combination-with-metformin-in-patients-with-type-2-diabetes-5604https://curecurrent.com/trials/a-helping-hand-among-low-income-patients-5605https://curecurrent.com/trials/diabetes-care-transformation-diabetes-data-registry-and-intensive-remote-monitoring-5606https://curecurrent.com/trials/multi-tracer-pet-quantitation-of-insulin-action-5607https://curecurrent.com/trials/closed-loop-insulin-pump-therapy-after-islet-auto-transplantation-5608https://curecurrent.com/trials/skeletal-muscle-lipid-and-insulin-resistance-effects-of-physical-activity-and-weight-loss-5609https://curecurrent.com/trials/reproducibility-of-hba1c-measurement-on-the-aina-hba1c-monitoring-system-5610https://curecurrent.com/trials/dietary-nitrate-and-exercise-to-augment-exercise-training-benefits-in-subjects-with-dm-pad-5611https://curecurrent.com/trials/observational-study-to-evaluate-the-effectiveness-and-safety-of-the-dexcom-g4-continuous-glucose-monitoring-system-in-pe-5612https://curecurrent.com/trials/the-usability-acceptability-and-perceived-value-of-the-cornerstones4care-powered-by-glooko-app-5613https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetic-a-single-day-of-dosing-with-gsk1614235-5614https://curecurrent.com/trials/a-study-to-determine-the-safety-tolerability-and-effects-of-gsk2374697-in-healthy-volunteers-5615https://curecurrent.com/trials/changes-in-bone-turnover-with-increased-incretin-hormone-exposure-5616https://curecurrent.com/trials/closed-loop-control-in-young-children-5-8-years-old-using-dias-platform-5617https://curecurrent.com/trials/effects-of-ranolazine-on-coronary-flow-reserve-in-symptomatic-diabetic-patients-and-cad-5618https://curecurrent.com/trials/physical-health-in-midlife-influences-of-adversity-and-relationships-over-time-5619https://curecurrent.com/trials/walnut-consumption-and-diabetes-risk-5620https://curecurrent.com/trials/outpatient-automated-blood-glucose-control-with-a-bi-hormonal-bionic-endocrine-pancreas-5621https://curecurrent.com/trials/a-study-of-the-pharmacokinetics-of-albiglutide-in-normal-and-renally-impaired-subjects-5622https://curecurrent.com/trials/treating-periodontal-infection-effects-on-glycemic-5623https://curecurrent.com/trials/dose-ranging-study-to-evaluate-efficacy-and-safety-of-weekly-cjc-1134-pc-in-patients-with-t2dm-on-metformin-monotherapy-5624https://curecurrent.com/trials/continuous-glucose-monitoring-in-women-with-type-1-diabetes-in-pregnancy-trial-5625https://curecurrent.com/trials/pet-scan-imaging-of-beta-cell-mass-5626https://curecurrent.com/trials/translating-the-dpp-into-the-community-5627https://curecurrent.com/trials/grafixprime-for-the-treatment-of-chronic-diabetic-foot-ulcers-5628https://curecurrent.com/trials/a-study-to-test-how-sb756050-affects-subjects-with-type-2-diabetes-mellitus-after-6-days-of-dosing-5629https://curecurrent.com/trials/social-forces-to-improve-statin-adherence-study-b-5630https://curecurrent.com/trials/interactive-spaced-education-to-optimize-diabetes-care-5631https://curecurrent.com/trials/rapamycin-versus-mycophenolate-mofetil-in-kidney-pancreas-recipients-5632https://curecurrent.com/trials/the-effect-of-pancreatic-polypeptide-on-insulin-requirements-for-type-1-post-pancreatectomy-diabetic-patients-5633https://curecurrent.com/trials/freestyle-libre-flash-glucose-monitoring-system-accuracy-study-5634https://curecurrent.com/trials/a-study-to-evaluate-the-effectiveness-safety-and-tolerability-of-canagliflozin-in-combination-with-metformin-in-the-trea-5635https://curecurrent.com/trials/a-phase-1-study-to-evaluate-the-safety-and-tolerability-of-gsk1362885-in-healthy-normal-subjects-5636https://curecurrent.com/trials/lifestyle-intervention-for-adults-with-diabetes-5637https://curecurrent.com/trials/inducing-remission-in-type-1-diabetes-with-alefacept-5638https://curecurrent.com/trials/a-prospective-randomized-double-blind-placebo-controlled-study-to-assess-the-impact-of-ormd-0801-insulin-capsules-on-the-5639https://curecurrent.com/trials/assessment-of-insulin-production-from-native-pancreas-in-patients-with-pancreas-transplants-5640https://curecurrent.com/trials/salivary-proteins-in-disease-and-health-5641https://curecurrent.com/trials/methods-for-measuring-insulin-sensitivity-5642https://curecurrent.com/trials/glycemic-response-to-six-meal-replacements-in-persons-with-type-2-diabetes-mellitus-5643https://curecurrent.com/trials/insulin-secretory-defects-in-pima-indians-at-high-risk-for-niddm-5644https://curecurrent.com/trials/metabolic-mapping-to-measure-retinal-metabolism-5645https://curecurrent.com/trials/anti-tac-therapy-for-uveitis-5646https://curecurrent.com/trials/assessment-of-beta-cell-mass-in-type-1-diabetes-with-11c-dihydrotetrabenazine-and-pet-scan-5647https://curecurrent.com/trials/interventions-to-educate-an-underserved-population-about-inherited-disease-risks-5648https://curecurrent.com/trials/pilot-study-of-mitochondrial-biology-in-human-platelets-5649https://curecurrent.com/trials/evaluation-of-patients-with-known-or-suspected-heart-disease-5650https://curecurrent.com/trials/evaluation-and-treatment-of-patients-with-retinal-disease-5651https://curecurrent.com/trials/screening-for-studies-on-retinovascular-diseases-5652https://curecurrent.com/trials/management-of-type-1-diabetes-among-adolescents-5653https://curecurrent.com/trials/differences-in-genes-and-proteins-in-active-and-controlled-uveitis-5654https://curecurrent.com/trials/eye-injections-of-triamcinolone-acetonide-for-retinal-blood-vessel-disorders-5655https://curecurrent.com/trials/pilot-study-of-laser-photocoagulation-therapy-for-diabetic-macular-edema-5656https://curecurrent.com/trials/identifying-the-role-of-oxytocin-and-vasopressin-in-the-functioning-of-neurocognitive-systems-involved-in-mood-disorders-5657https://curecurrent.com/trials/mapping-of-end-stage-renal-disease-genetic-susceptibility-in-african-americans-by-admixture-linkage-disequilibrium-5658https://curecurrent.com/trials/delaying-the-progression-of-diabetic-nephropathy-in-pima-indians-5659https://curecurrent.com/trials/rosiglitazone-to-reverse-metabolic-defects-in-diabetes-5660https://curecurrent.com/trials/accuracy-of-hemoglobin-a1c-to-predict-glycemia-in-hiv-5661https://curecurrent.com/trials/treatment-of-diabetic-macular-edema-triamcinolone-injections-vs-laser-photocoagulation-5662https://curecurrent.com/trials/autologous-stem-cell-and-hyperbaric-oxygen-therapy-in-type-2-diabetes-mellitus-5663https://curecurrent.com/trials/relation-of-white-blood-cell-function-to-diabetes-5664https://curecurrent.com/trials/the-roles-of-trust-and-respect-in-patient-reactions-to-race-based-and-personalized-medicine-vignettes-an-experimental-st-5665https://curecurrent.com/trials/intravitreal-v-sub-tenon-injections-of-triamcinolone-acetonide-for-macular-edema-in-retinal-disorders-5666https://curecurrent.com/trials/diabetes-management-personal-trainer-5667https://curecurrent.com/trials/pilot-study-to-assess-the-proteome-in-human-atrial-tissue-5668https://curecurrent.com/trials/rosiglitazone-to-treat-patients-with-heart-failure-and-glucose-intolerance-or-type-ii-diabetes-5669https://curecurrent.com/trials/blood-factors-and-diabetic-retinopathy-5670https://curecurrent.com/trials/food-intake-and-appetite-in-the-children-of-mothers-with-diabetes-5671https://curecurrent.com/trials/effect-of-testosterone-in-men-with-erectile-dysfunction-5672https://curecurrent.com/trials/glycemic-effects-of-morning-only-evening-only-or-twice-daily-insulin-glargine-in-patients-with-type-1-diabetes-5673https://curecurrent.com/trials/comparison-of-outreach-approaches-to-increase-enrollment-in-a-healthy-cholesterol-study-5674https://curecurrent.com/trials/neox-cord-1k-vs-standard-of-care-in-non-healing-diabetic-foot-ulcers-5675https://curecurrent.com/trials/colesevelam-as-add-on-to-pioglitazone-therapy-for-type-2-diabetes-mellitus-5676https://curecurrent.com/trials/cinnamon-bark-water-soluble-cinnamon-extract-and-metformin-for-treatment-of-type-2-dm-5677https://curecurrent.com/trials/safety-and-efficacy-of-saxagliptin-for-glycemic-control-in-non-critically-ill-hospitalized-patient-5678https://curecurrent.com/trials/a-drug-interaction-study-with-albiglutide-and-warfarin-5679https://curecurrent.com/trials/reducing-problematic-substance-use-in-youth-with-chronic-medical-conditions-5680https://curecurrent.com/trials/effects-of-exenatide-on-liver-biochemistry-liver-histology-and-lipid-metabolism-in-patients-with-fatty-liver-disease-5681https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-gsk1362885-in-type-2-diabetics-5682https://curecurrent.com/trials/first-time-in-human-study-using-gsk2330672-5683https://curecurrent.com/trials/examining-the-effects-of-diet-on-health-in-prediabetes-with-an-online-program-5684https://curecurrent.com/trials/utlight-transcranial-doppler-assessment-of-regional-cerebral-autoregulation-5685https://curecurrent.com/trials/intervention-using-vitamin-d-for-elevated-urinary-albumin-treated-with-losartan-in-diabetes-ideal-5686https://curecurrent.com/trials/using-health-information-technology-hit-to-improve-ambulatory-chronic-disease-care-smart-device-substudy-5687https://curecurrent.com/trials/mechanisms-underlying-metabolic-syndrome-in-obesity-5688https://curecurrent.com/trials/effect-of-dapagliflozin-on-24-hour-blood-glucose-in-t2dm-patients-inadequately-controlled-with-either-metformin-or-insul-5689https://curecurrent.com/trials/clinical-protocol-to-investigate-the-efficacy-of-recombinant-human-leptin-metreleptin-in-nonalcoholic-steatohepatitis-na-5690https://curecurrent.com/trials/a-study-to-investigate-the-interaction-of-gsk1292263-with-rosuvastatin-and-simvastatin-in-healthy-subjects-5691https://curecurrent.com/trials/changes-in-bone-turnover-with-exposure-to-a-glp-1-receptor-agonist-5692https://curecurrent.com/trials/role-of-mineralocorticoid-receptor-in-diabetic-cardiovascular-disease-5693https://curecurrent.com/trials/an-evaluation-of-the-pharmacokinetics-of-an-oral-contraceptive-brevicon-when-co-administered-with-albiglutide-5694https://curecurrent.com/trials/pancreatic-islet-cell-transplantation-5695https://curecurrent.com/trials/a-phase-1-study-to-evaluate-the-effect-of-gsk256073-an-hm74a-receptor-agonist-on-glucose-and-nefa-levels-in-type-2-diabe-5696https://curecurrent.com/trials/mhealth-skill-enhancement-plus-phone-cbt-for-type-2-diabetes-distress-medication-nonadherence-pilot-study-5697https://curecurrent.com/trials/reteval-study-for-diabetic-retinopathy-5698https://curecurrent.com/trials/use-of-the-paradigm-722-system-to-improve-glycemic-control-in-adult-and-adolescent-subjects-with-type-1-diabetes-5699https://curecurrent.com/trials/a-drug-interaction-study-of-albiglutide-and-digoxin-5700https://curecurrent.com/trials/protocol-for-the-evaluation-of-dario-bgms-performance-at-elevated-altitude-5701https://curecurrent.com/trials/type-one-diabetes-and-low-carb-study-5702https://curecurrent.com/trials/a-drug-interaction-study-of-simvastatin-and-albiglutide-5703https://curecurrent.com/trials/a-2-part-trial-in-subjects-with-type-2-diabetes-and-in-healthy-subjects-to-evaluate-gsk1614235-a-new-glucose-lowering-dr-5704https://curecurrent.com/trials/a-feasibility-study-of-advance-plasma-therapy001-plasma-nitric-oxide-therapy-for-the-treatment-of-diabetic-foot-ulcers-5705https://curecurrent.com/trials/patient-and-provider-attitudes-in-the-healthcare-context-5706https://curecurrent.com/trials/pilot-and-feasibility-study-for-the-treatment-of-pre-diabetes-in-patients-with-cystic-fibrosis-5707https://curecurrent.com/trials/neurobiological-bases-of-paternal-nurturance-5708https://curecurrent.com/trials/study-of-intensive-home-based-family-therapy-to-improve-illness-management-in-youth-with-diabetes-5709https://curecurrent.com/trials/testing-mst-to-improve-adherence-among-youth-with-chronic-poor-metabolic-control-5710https://curecurrent.com/trials/program-reinforcement-impacts-self-management-prism-5711https://curecurrent.com/trials/computerized-intervention-of-parental-involvement-in-diabetes-care-of-their-child-5712https://curecurrent.com/trials/home-based-interventions-for-adolescents-with-type-1-diabetes-5713https://curecurrent.com/trials/reducing-stress-in-adolescents-and-young-adults-with-type-1-diabetes-to-improve-diabetes-care-5714https://curecurrent.com/trials/effects-of-dpp-4-inhibition-on-calcium-and-bone-metabolism-in-type-2-diabetes-mellitus-5715https://curecurrent.com/trials/the-effect-of-vasopressin-on-glucose-regulation-5716https://curecurrent.com/trials/liraglutide-in-obesity-and-diabetes-identification-of-cns-targets-using-fmri-5717https://curecurrent.com/trials/sitagliptin-therapy-to-improve-outcomes-after-islet-autotransplant-5718https://curecurrent.com/trials/compare-effects-of-a-soluble-fiber-on-weight-and-blood-cholesterol-5719https://curecurrent.com/trials/pk-study-of-dapagliflozin-in-pediatric-subjects-with-t2dm-5720https://curecurrent.com/trials/can-whey-protein-improve-glycemic-control-in-type-2-diabetes-5721https://curecurrent.com/trials/glycemic-control-using-insulin-levemir-versus-insulin-nph-for-diabetes-in-pregnancy-5722https://curecurrent.com/trials/glycemic-stability-of-insulin-aspart-versus-insulin-lispro-in-insulin-pump-therapy-5723https://curecurrent.com/trials/sitagliptin-therapy-in-hospitalized-patients-with-type-2-diabetes-5724https://curecurrent.com/trials/one-day-acceptance-and-commitment-training-intervention-in-primary-care-patients-5725https://curecurrent.com/trials/steroid-free-and-long-term-calcineurin-free-trial-in-islet-cell-transplantation-5726https://curecurrent.com/trials/continuous-glucose-monitoring-evaluation-of-exenatide-twice-daily-versus-insulin-glargine-5727https://curecurrent.com/trials/a-clinical-trial-comparing-efficacy-and-safety-of-insulin-degludec-liraglutide-ideglira-in-subjects-with-type-2-diabetes-5728https://curecurrent.com/trials/pedometers-for-gestational-diabetes-5729https://curecurrent.com/trials/three-way-cross-over-closed-loop-exercise-study-5730https://curecurrent.com/trials/autoimmunity-blocking-antibody-for-tolerance-in-recently-diagnosed-type-1-diabetes-5731https://curecurrent.com/trials/insulin-glargine-at-bedtime-or-in-am-versus-nph-5732https://curecurrent.com/trials/prospective-study-of-the-impact-of-insulin-pump-therapy-in-young-children-with-type-1-diabetes-5733https://curecurrent.com/trials/behavioral-family-systems-therapy-bfst-for-teens-with-type-2-diabetes-5734https://curecurrent.com/trials/efficacy-and-safety-of-three-doses-of-vildagliptin-in-drug-naive-patients-with-type-2-diabetes-5735https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-compared-to-rosiglitazone-in-drug-naive-patients-with-type-2-diabetes-5736https://curecurrent.com/trials/pilot-study-of-using-copeptin-to-predict-response-to-tolvaptan-5737https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-in-combination-with-pioglitazone-in-drug-naive-patients-with-type-2-diabetes-5738https://curecurrent.com/trials/postmarket-study-to-evaluate-biovance-in-diabetic-foot-ulcers-5739https://curecurrent.com/trials/safety-and-efficacy-of-aliskiren-when-added-to-standardized-losartan-and-optimal-antihypertensive-therapy-in-patients-wi-5740https://curecurrent.com/trials/study-of-calcium-metabolism-in-teenage-girls-with-type-1-diabetes-5741https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-safety-and-efficacy-of-aliskiren-alone-and-in-combination-with-ramipril-in-hypertensive-5742https://curecurrent.com/trials/effectiveness-of-subcutaneous-glargine-on-the-time-to-closure-of-the-anion-gap-in-patients-presenting-to-the-emergency-d-5743https://curecurrent.com/trials/cgm-to-aid-transition-from-inpatient-to-outpatient-5744https://curecurrent.com/trials/assessment-of-an-intervention-to-prevent-obesity-and-diabetes-in-latino-farm-workers-5745https://curecurrent.com/trials/safety-and-efficacy-of-combination-saxagliptin-dapagliflozin-added-to-metformin-to-treat-subjects-with-type-2-diabetes-5746https://curecurrent.com/trials/multiple-daily-injections-and-continuous-glucose-monitoring-in-diabetes-5747https://curecurrent.com/trials/computer-automation-for-diagnosis-and-management-of-childhood-type-2-diabetes-5748https://curecurrent.com/trials/diabetic-retinopathy-and-the-myvisiontrack-drama-study-5749https://curecurrent.com/trials/evaluation-of-an-ascensia-lancing-system-5750https://curecurrent.com/trials/effect-of-angiotensin-converting-enzyme-inhibitor-lisinopril-on-renal-blood-flow-and-its-correlation-with-proteinuria-re-5751https://curecurrent.com/trials/corticosteroid-therapy-on-glucose-control-in-pregnant-women-with-diabetes-5752https://curecurrent.com/trials/study-of-antithymocyte-globulin-for-treatment-of-new-onset-t1dm-5753https://curecurrent.com/trials/a-pilot-study-of-bms-512148-in-subjects-with-type-2-diabetes-5754https://curecurrent.com/trials/effect-of-empagliflozin-kinetics-on-renal-glucose-reabsorption-in-patients-with-type-ii-diabetes-and-healthy-controls-5755https://curecurrent.com/trials/effect-of-the-direct-renin-inhibitor-aliskiren-on-endothelial-function-and-arterial-stiffness-in-diabetic-subjects-5756https://curecurrent.com/trials/comprehensive-intervention-to-evaluate-outcomes-and-cost-in-hospitalized-surgical-patients-with-diabetes-mellitus-dm-5757https://curecurrent.com/trials/lifestyle-improvement-through-food-and-exercise-life-study-5758https://curecurrent.com/trials/evaluation-of-the-precision-of-the-microperimetry-function-of-the-spectral-oct-slo-5759https://curecurrent.com/trials/reduction-of-nocturnal-hypoglycemia-and-hyperglycemia-in-the-home-using-predictive-algorithms-pump-suspension-and-insuli-5760https://curecurrent.com/trials/efficacy-and-safety-of-the-insulin-glargine-lixisenatide-fixed-ratio-combination-versus-insulin-glargine-in-patients-wit-5761https://curecurrent.com/trials/tablet-aided-behavioral-intervention-effect-on-self-management-skills-5762https://curecurrent.com/trials/lovaza-and-microvascular-function-in-type-2-diabetes-5763https://curecurrent.com/trials/improving-diabetes-outcomes-for-persons-with-severe-mental-illness-5764https://curecurrent.com/trials/a-comparison-of-tcc-ez-using-human-amnion-allograft-vs-tcc-ez-and-standard-wound-care-in-treating-diabetic-foot-ulcers-5765https://curecurrent.com/trials/efficacy-and-safety-of-insulin-glargine-lixisenatide-fixed-ratio-combination-compared-to-insulin-glargine-alone-and-lixi-5766https://curecurrent.com/trials/diabetes-remote-care-management-system-5767https://curecurrent.com/trials/retinal-vessel-measurements-as-clinically-useful-predictors-in-veterans-5768https://curecurrent.com/trials/the-effects-of-vitamin-d-on-glycemic-control-and-proinflammatory-markers-in-adolescents-with-t1dm-5769https://curecurrent.com/trials/optical-imaging-for-assessment-of-foot-perfusion-5770https://curecurrent.com/trials/nyulmc-caresmarts-pilot-5771https://curecurrent.com/trials/a-clinical-trial-to-evaluate-pf-05089771-on-its-own-and-as-an-add-on-therapy-to-pregabalin-lyrica-for-the-treatment-of-p-5772https://curecurrent.com/trials/the-effect-of-a-coloring-prompt-on-health-engagement-5773https://curecurrent.com/trials/role-of-gastrointestinal-microbes-on-digestion-of-resistant-starch-and-tryptophan-availability-to-humans-5774https://curecurrent.com/trials/medicaid-incentives-for-the-prevention-of-chronic-diseases-diabetes-prevention-5775https://curecurrent.com/trials/effectiveness-of-patient-centered-community-health-worker-support-to-help-patients-control-chronic-disease-5776https://curecurrent.com/trials/fresh-start-experiment-5777https://curecurrent.com/trials/impact-of-dietary-intervention-on-weight-change-in-subjects-with-type-2-diabetes-5778https://curecurrent.com/trials/neat-technology-to-increase-breaks-in-sedentary-behavior-in-adults-with-diabetes-5779https://curecurrent.com/trials/health-information-technology-hit-enhanced-family-history-documentation-and-management-in-primary-care-5780https://curecurrent.com/trials/ranibizumab-for-edema-of-the-macula-in-diabetes-protocol-3-with-high-dose-the-read-3-study-5781https://curecurrent.com/trials/gapp-1-survey-global-attitudes-of-patients-and-physicians-in-insulin-therapy-for-diabetes-mellitus-5782https://curecurrent.com/trials/long-term-clinical-evaluation-of-sls-transtibial-sockets-5783https://curecurrent.com/trials/evaluation-of-fats-on-postprandial-glucose-control-5784https://curecurrent.com/trials/effect-of-dietary-fat-on-glycemic-control-in-type-1-diabetes-5785https://curecurrent.com/trials/the-effect-of-pecans-on-biomarkers-of-risk-for-cardiovascular-disease-and-diabetes-5786https://curecurrent.com/trials/glycemic-index-variability-among-individuals-5787https://curecurrent.com/trials/improving-self-management-skills-of-older-adults-with-diabetes-5788https://curecurrent.com/trials/effectiveness-of-metformin-compared-to-insulin-in-pregnant-women-with-mild-preexisting-or-early-gestational-diabetes-5789https://curecurrent.com/trials/induced-and-controlled-dietary-ketosis-as-a-regulator-of-obesity-and-metabolic-syndrome-pathologies-5790https://curecurrent.com/trials/the-effect-of-tight-glycemic-control-on-surgical-site-infection-rates-in-patients-undergoing-open-heart-surgery-5791https://curecurrent.com/trials/role-of-growth-hormone-antagonism-in-modulating-insulin-sensitivity-in-subjects-with-pre-diabetes-5792https://curecurrent.com/trials/the-effects-of-puberty-and-weight-on-sugar-metabolism-in-children-5793https://curecurrent.com/trials/the-role-of-amylin-and-incretins-on-postprandial-metabolisms-in-adolescents-with-type-2-diabetes-mellitus-t2dm-5794https://curecurrent.com/trials/pancreatic-islet-cell-transplantation-a-novel-approach-to-improve-islet-quality-and-engraftment-5795https://curecurrent.com/trials/a-pilot-study-to-assess-the-glucose-lowering-effect-of-metformin-and-sitagliptin-in-adolescents-with-type-1-diabetes-5796https://curecurrent.com/trials/the-effect-of-byetta-and-symlin-on-post-meal-meal-blood-sugar-levels-in-children-with-type-2-diabetes-5797https://curecurrent.com/trials/effects-of-dapagliflozin-on-insulin-resistance-and-insulin-secretion-in-subjects-with-type-2-diabetes-5798https://curecurrent.com/trials/safety-and-efficacy-of-dapagliflozin-as-monotherapy-in-subjects-with-type-2-diabetes-5799https://curecurrent.com/trials/primary-intervention-with-mucosal-insulin-5800https://curecurrent.com/trials/metabolomic-analysis-of-hepatic-insulin-resistance-5801https://curecurrent.com/trials/transcutaneous-raman-spectroscope-trs-analyses-of-diabetic-foot-ulcers-5802https://curecurrent.com/trials/mindfulness-a-novel-approach-for-the-management-of-diabetes-related-distress-5803https://curecurrent.com/trials/examining-the-role-of-cgm-in-t2dm-5804https://curecurrent.com/trials/thiazolidinedione-intervention-with-vitamin-d-evaluation-5805https://curecurrent.com/trials/a-safety-and-pharmacokinetic-study-of-cvx-096-in-type-2-diabetics-5806https://curecurrent.com/trials/a-multicenter-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-saxagliptin-bms-47-5807https://curecurrent.com/trials/effect-of-increasing-testosterone-on-insulin-sensitivity-in-men-with-the-metabolic-syndrome-5808https://curecurrent.com/trials/efficacy-and-safety-of-lixisenatide-versus-placebo-on-top-of-basal-insulin-and-or-oral-antidiabetic-treatment-in-older-t-5809https://curecurrent.com/trials/study-to-evaluate-the-efficacy-safety-tolerability-and-pharmacokinetics-of-saxagliptin-as-monotherapy-in-pediatric-patie-5810https://curecurrent.com/trials/characteristics-of-glargine-in-type-2-diabetics-5811https://curecurrent.com/trials/fast-track-csii-using-a-novel-device-in-young-children-with-newly-diagnosed-t1dm-5812https://curecurrent.com/trials/early-phase-pre-clinical-and-initial-clinical-research-on-epicatechin-5813https://curecurrent.com/trials/effect-of-nutritional-products-in-subjects-with-type-2-diabetes-5814https://curecurrent.com/trials/gluten-immunity-and-islet-autoimmunity-in-type-1-diabetes-5815https://curecurrent.com/trials/prevalence-of-vitamin-d-deficiency-in-type-1-diabetes-mellitus-and-effect-of-supplementation-on-insulin-requirements-5816https://curecurrent.com/trials/randomized-study-of-real-time-continuous-glucose-monitors-rt-cgm-in-the-management-of-type-1-diabetes-5817https://curecurrent.com/trials/bioavailability-and-biological-effects-of-vitamin-d2-contained-in-mushroom-5818https://curecurrent.com/trials/evaluate-safety-of-technosphere-insulin-ti-in-diabetic-subjects-with-moderate-obstructive-pulmonary-disease-5819https://curecurrent.com/trials/bd-flowsmart-subcutaneous-insulin-infusion-set-user-preference-and-claims-study-5820https://curecurrent.com/trials/genetics-of-latent-autoimmune-diabetes-in-adults-5821https://curecurrent.com/trials/feasibility-study-of-digital-photography-and-group-discussion-for-people-with-diabetes-5822https://curecurrent.com/trials/smoking-cessation-intervention-for-diabetic-patients-5823https://curecurrent.com/trials/islet-cell-transplantation-in-patients-with-type-i-diabetes-with-previous-kidney-transplantation-5824https://curecurrent.com/trials/brief-alcohol-intervention-to-reduce-at-risk-drinking-among-type-2-diabetics-5825https://curecurrent.com/trials/processing-responses-of-grains-pro-grains-study-5826https://curecurrent.com/trials/the-validate-d-study-5827https://curecurrent.com/trials/par-regulation-of-platelet-function-in-diabetic-patients-5828https://curecurrent.com/trials/study-of-the-effect-on-clinical-outcomes-using-secure-text-messaging-5829https://curecurrent.com/trials/imaging-of-type-1-diabetes-progression-5830https://curecurrent.com/trials/incretin-regulation-of-insulin-secretion-in-monogenic-diabetes-5831https://curecurrent.com/trials/effects-of-continuous-positive-airway-pressure-cpap-treatment-on-glucose-control-in-patients-with-type-2-diabetes-5832https://curecurrent.com/trials/confronting-unequal-eye-care-in-pennsylvania-5833https://curecurrent.com/trials/safety-study-of-topical-doxycycline-gel-for-adult-diabetic-lower-extremity-ulcers-5834https://curecurrent.com/trials/a-trial-comparing-efficacy-and-safety-of-insulin-degludec-and-insulin-glargine-in-insulin-na-ve-subjects-with-type-2-dia-5835https://curecurrent.com/trials/aldosterone-and-glucose-homeostasis-5836https://curecurrent.com/trials/comparison-of-nn1250-plus-insulin-aspart-with-insulin-glargine-plus-insulin-aspart-in-type-1-diabetes-5837https://curecurrent.com/trials/comparison-of-nn1250-with-insulin-glargine-plus-insulin-aspart-with-without-metformin-and-with-without-pioglitazone-in-t-5838https://curecurrent.com/trials/glargine-dosing-in-hospitalized-patients-with-type-2-diabetes-and-renal-insufficiency-5839https://curecurrent.com/trials/truskin-study-for-the-treatment-of-chronic-diabetic-foot-ulcers-5840https://curecurrent.com/trials/changing-the-healthcare-delivery-model-5841https://curecurrent.com/trials/a-3-month-clinical-trial-to-assess-the-safety-and-efficacy-of-the-ozurdex-intraocular-implant-in-patients-with-diabetes-5842https://curecurrent.com/trials/university-of-texas-h-s-c-san-antonio-pioglitazone-in-non-alcoholic-steatohepatitis-trial-uthscsa-nash-trial-5843https://curecurrent.com/trials/behavioral-economics-incentives-for-health-management-5844https://curecurrent.com/trials/islet-cell-transplantation-alone-and-cd34-donor-bone-marrow-cell-infusion-in-type-1-diabetes-mellitus-5845https://curecurrent.com/trials/effect-of-renal-impairment-on-the-pharmacokinetics-of-nn9535-5846https://curecurrent.com/trials/the-ranibizumab-for-edema-of-the-macula-in-diabetes-2-read-2-study-5847https://curecurrent.com/trials/propranolol-for-diabetic-retinopathy-5848https://curecurrent.com/trials/gestational-diabetes-follow-up-study-5849https://curecurrent.com/trials/strength-training-and-nutrition-development-for-african-american-youth-5850https://curecurrent.com/trials/strength-and-nutrition-outcomes-for-latino-adolescents-5851https://curecurrent.com/trials/islet-transplantation-in-type-1-diabetic-patients-5852https://curecurrent.com/trials/glycemic-control-and-complications-in-diabetes-mellitus-type-2-vadt-5853https://curecurrent.com/trials/efficacy-and-safety-of-liraglutide-in-subjects-with-type-1-diabetes-undergoing-islet-cell-transplantation-5854https://curecurrent.com/trials/non-invasive-assessment-of-wound-healing-with-optical-methods-5855https://curecurrent.com/trials/diet-as-a-potential-treatment-for-autosomal-dominant-polycystic-kidney-disease-5856https://curecurrent.com/trials/assess-the-efficacy-of-the-low-glucose-suspend-lgs-feature-in-the-minimed-paradigm-x54-system-5857https://curecurrent.com/trials/comparison-of-the-effectiveness-and-tolerability-of-exenatide-once-weekly-compared-to-basal-insulins-5858https://curecurrent.com/trials/phase-2-study-to-evaluate-safety-efficacy-of-vpi-2690b-in-diabetic-nephropathy-patients-5859https://curecurrent.com/trials/the-effect-of-aliskiren-on-endothelial-function-in-pre-diabetes-and-diabetes-5860https://curecurrent.com/trials/efficacy-safety-and-preference-study-of-a-insulin-pen-pds290-vs-a-novo-nordisk-marketed-insulin-pen-in-diabetics-5861https://curecurrent.com/trials/the-effects-of-alpha-1-antitrypsin-aat-on-the-progression-of-type-1-diabetes-5862https://curecurrent.com/trials/rosiglitazone-versus-a-sulfonylurea-on-progression-of-atherosclerosis-in-patients-with-heart-disease-and-type-2-diabetes-5863https://curecurrent.com/trials/study-in-people-with-type-2-diabetes-5864https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-liraglutide-depot-in-healthy-subjects-5865https://curecurrent.com/trials/a-randomised-trial-comparing-efficacy-and-safety-after-intensification-with-either-insulin-aspart-once-daily-as-add-on-o-5866https://curecurrent.com/trials/the-fasting-ii-study-5867https://curecurrent.com/trials/a-study-of-ly2405319-in-participants-with-type-2-diabetes-5868https://curecurrent.com/trials/the-fenofibrate-and-metformin-for-atherogenic-dyslipidemia-fama-study-5869https://curecurrent.com/trials/changes-in-inflammatory-state-in-asian-americans-changing-from-traditional-asian-diets-to-american-diet-a-pilot-study-5870https://curecurrent.com/trials/comparison-of-nn5401-plus-insulin-aspart-with-insulin-detemir-plus-insulin-aspart-in-type-1-diabetes-5871https://curecurrent.com/trials/comparison-of-nn5401-with-insulin-glargine-both-in-combination-with-oral-antidiabetic-drugs-in-subjects-with-type-2-diab-5872https://curecurrent.com/trials/together-on-diabetes-study-evaluation-of-a-pilot-diabetes-prevention-and-management-program-for-american-indian-youth-5873https://curecurrent.com/trials/efficacy-and-safety-of-insulin-degludec-insulin-aspart-in-insulin-na-ve-subjects-with-type-2-diabetes-using-two-dosing-r-5874https://curecurrent.com/trials/assessment-of-an-automatic-closed-loop-insulin-delivery-system-5875https://curecurrent.com/trials/screening-for-asymptomatic-obstructive-coronary-artery-disease-among-high-risk-diabetic-patients-using-ct-angiography-fo-5876https://curecurrent.com/trials/safety-and-efficacy-study-of-correcting-hyperglycemia-in-patients-with-diabetes-having-out-patient-surgery-5877https://curecurrent.com/trials/islet-transplantation-for-type-1-diabetes-5878https://curecurrent.com/trials/use-of-santyl-within-an-accountable-care-organization-5879https://curecurrent.com/trials/effect-of-detemir-and-sitagliptin-on-blood-glucose-control-in-type-2-diabetes-5880https://curecurrent.com/trials/insulin-clamp-ancillary-study-for-assessment-of-insulin-resistance-5881https://curecurrent.com/trials/promoting-adherence-to-improve-effectiveness-of-cardiovascular-disease-therapies-5882https://curecurrent.com/trials/atorvastatin-in-new-onset-type-1-diabetes-mellitus-t1dm-5883https://curecurrent.com/trials/effect-of-two-different-fasting-blood-glucose-targets-on-glucose-control-in-patients-with-type-2-diabetes-using-insulin-5884https://curecurrent.com/trials/comparison-of-the-blood-sugar-lowering-effect-and-safety-of-two-insulin-treatments-in-type-2-diabetes-5885https://curecurrent.com/trials/effect-of-insulin-detemir-and-insulin-glargine-on-blood-glucose-control-in-subjects-with-type-2-diabetes-5886https://curecurrent.com/trials/a-trial-to-assess-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-single-doses-of-pf-04937319-in-subjec-5887https://curecurrent.com/trials/pilot-study-of-bydureon-to-treat-diabetes-in-hiv-infected-adults-5888https://curecurrent.com/trials/mga031-sirolimus-and-tacrolimus-in-islet-transplantation-5889https://curecurrent.com/trials/one-step-versus-two-step-approach-for-gestational-diabetes-mellitus-screening-5890https://curecurrent.com/trials/community-based-diabetes-care-for-korean-american-immigrants-5891https://curecurrent.com/trials/effects-of-dapagliflozin-on-kidney-function-glomerular-filtration-rate-in-subjects-with-type-2-diabetes-5892https://curecurrent.com/trials/effect-of-liraglutide-or-exenatide-added-to-an-ongoing-treatment-on-blood-glucose-control-in-subjects-with-type-2-diabet-5893https://curecurrent.com/trials/the-effect-of-insulin-detemir-in-combination-with-liraglutide-and-metformin-compared-to-liraglutide-and-metformin-in-sub-5894https://curecurrent.com/trials/the-effect-of-liraglutide-versus-placebo-when-added-to-basal-insulin-analogues-with-or-without-metformin-in-subjects-wit-5895https://curecurrent.com/trials/the-effect-of-liraglutide-on-endothelial-function-in-subjects-with-type-2-diabetes-mellitus-5896https://curecurrent.com/trials/the-effect-of-liraglutide-compared-to-sitagliptin-both-in-combination-with-metformin-on-glycaemic-control-in-subjects-wi-5897https://curecurrent.com/trials/to-evaluate-the-effect-of-liraglutide-versus-glimepiride-amaryl-on-haemoglobin-a1c-5898https://curecurrent.com/trials/a-trial-comparing-the-efficacy-patient-reported-outcomes-and-safety-of-insulin-degludec-200-u-ml-vs-insulin-glargine-in-5899https://curecurrent.com/trials/comparing-the-efficacy-and-safety-of-nn1250-once-daily-when-titrated-using-2-different-algorithms-in-insulin-na-ve-subje-5900https://curecurrent.com/trials/comparison-of-the-efficacy-and-safety-of-two-intensification-strategies-in-subjects-with-type-2-diabetes-inadequately-co-5901https://curecurrent.com/trials/the-efficacy-and-safety-of-liraglutide-as-adjunct-therapy-to-insulin-in-the-treatment-of-type-1-diabetes-5902https://curecurrent.com/trials/comparison-of-two-insulin-degludec-formulations-in-subjects-with-type-2-diabetes-mellitus-5903https://curecurrent.com/trials/marlina-t2d-efficacy-safety-modification-of-albuminuria-in-type-2-diabetes-subjects-with-renal-disease-with-linagliptin-5904https://curecurrent.com/trials/comparison-of-nn1250-with-insulin-glargine-in-subjects-with-type-2-diabetes-5905https://curecurrent.com/trials/comparison-of-nn1250-with-insulin-glargine-in-subjects-with-type-2-diabetes-5906https://curecurrent.com/trials/comparison-of-nn1250-with-insulin-glargine-in-subjects-with-type-2-diabetes-5907https://curecurrent.com/trials/t1-diabetes-hypoglycemia-prevention-pilot-5908https://curecurrent.com/trials/comparison-of-two-nn1250-formulations-versus-insulin-glargine-all-in-combination-with-insulin-aspart-in-subjects-with-ty-5909https://curecurrent.com/trials/comparison-of-nn1250-with-sitagliptin-in-subjects-with-type-2-diabetes-never-treated-with-insulin-5910https://curecurrent.com/trials/evaluation-of-blood-pressure-reduction-safety-and-tolerability-of-canagliflozin-in-patients-with-hypertension-and-type-2-5911https://curecurrent.com/trials/a-phase-i-single-ascending-dose-study-of-the-intravitreal-plasma-kallikrein-inhibitor-kvd001-in-subjects-with-dme-5912https://curecurrent.com/trials/a-pilot-study-of-nocturnal-hypoglycemia-prevention-in-type-1-diabetes-using-the-vigilant-diabetes-management-companion-5913https://curecurrent.com/trials/comparison-of-two-nn1250-formulations-versus-insulin-glargine-all-in-combination-with-metformin-in-subjects-with-type-2-5914https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetics-pharmacodynamics-and-safety-of-canagliflozin-in-older-children-and-adolescents-5915https://curecurrent.com/trials/efficacy-of-exenatide-lar-and-dapagliflozin-in-overweight-obese-insulin-treated-patients-with-type-2-diabetes-5916https://curecurrent.com/trials/impaired-wound-healing-in-diabetic-foot-ulceration-5917https://curecurrent.com/trials/extension-to-a-study-on-the-efficacy-and-safety-of-vildagliptin-in-combination-with-metformin-in-patients-with-type-2-di-5918https://curecurrent.com/trials/extension-to-a-study-to-assess-the-efficacy-and-safety-of-three-doses-of-vildagliptin-in-patients-with-type-2-diabetes-5919https://curecurrent.com/trials/extension-to-a-study-on-the-efficacy-and-safety-of-vildagliptin-in-combination-with-glimepiride-in-patients-with-type-2-5920https://curecurrent.com/trials/evaluation-of-exenatide-in-patients-with-diabetic-neuropathy-5921https://curecurrent.com/trials/the-effect-of-add-on-canagliflozin-in-patients-with-type-2-diabetes-treated-with-u-500-insulin-5922https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-albiglutide-in-subjects-with-type-2-diabetes-with-renal-impairment-5923https://curecurrent.com/trials/cardiovascular-outcomes-study-of-naltrexone-sr-bupropion-sr-in-overweight-and-obese-subjects-with-cardiovascular-risk-fa-5924https://curecurrent.com/trials/mindfulness-based-personalized-health-planning-for-reducing-risk-of-heart-disease-and-diabetes-5925https://curecurrent.com/trials/autonomic-function-in-obstructive-sleep-apnea-5926https://curecurrent.com/trials/safety-and-efficacy-of-nateglinide-in-patients-with-type-2-diabetes-already-taking-insulin-glargine-metformin-and-or-pio-5927https://curecurrent.com/trials/efficacy-of-biphasic-insulin-aspart-30-in-type-2-diabetics-failing-on-oads-5928https://curecurrent.com/trials/thrombospondin-1-and-pigmented-epithelium-derived-factor-levels-in-patients-with-diabetes-mellitus-5929https://curecurrent.com/trials/a-study-to-determine-the-efficacy-and-safety-of-albiglutide-as-compared-with-liraglutide-5930https://curecurrent.com/trials/the-cantata-m-canagliflozin-treatment-and-trial-analysis-monotherapy-trial-5931https://curecurrent.com/trials/the-mobile-health-platform-5932https://curecurrent.com/trials/a-study-of-aleglitazar-in-combination-with-metformin-in-patients-with-type-2-diabetes-mellitus-who-are-inadequately-cont-5933https://curecurrent.com/trials/designer-functional-foods-on-parameters-of-metabolic-and-vascular-in-prediabetes-5934https://curecurrent.com/trials/effect-of-vildagliptin-on-fat-and-muscle-metabolism-in-patients-with-type-2-diabetes-5935https://curecurrent.com/trials/exploring-folk-health-practices-in-latinos-with-chronic-medical-conditions-5936https://curecurrent.com/trials/regulating-efficacy-and-wellness-in-diabetes-5937https://curecurrent.com/trials/extension-to-a-study-on-the-efficacy-and-safety-of-vildagliptin-in-combination-with-pioglitazone-in-patients-with-type-2-5938https://curecurrent.com/trials/add-on-to-thiazolidinedione-tzd-failures-5939https://curecurrent.com/trials/effect-of-repaglinide-on-postprandial-lipemia-in-type-2-diabetes-5940https://curecurrent.com/trials/efficacy-and-safety-of-basal-bolus-therapy-comparing-stepwise-addition-of-insulin-aspart-versus-complete-basal-bolus-reg-5941https://curecurrent.com/trials/a-6-week-study-of-pf-05175157-in-type-2-diabetes-mellitus-5942https://curecurrent.com/trials/evaluation-of-blood-glucose-monitoring-systems-with-blood-samples-from-neonates-5943https://curecurrent.com/trials/pancreatic-islet-cell-transplantation-after-kidney-transplantation-a-novel-approach-to-immunosupression-5944https://curecurrent.com/trials/a-study-to-evaluate-safety-and-efficacy-of-ttp054-for-12-weeks-in-subjects-with-type-2-diabetes-5945https://curecurrent.com/trials/efficacy-and-safety-of-insulin-glargine-lixisenatide-fixed-combination-versus-insulin-glargine-alone-on-top-of-metformin-5946https://curecurrent.com/trials/add-glucokinase-activator-to-target-a1c-5947https://curecurrent.com/trials/bms-safety-pharmacokinetics-pk-and-pharmacodynamics-pd-of-dapagliflozin-in-type-1-diabetes-5948https://curecurrent.com/trials/a-study-to-evaluate-safety-and-efficacy-of-ttp273-for-12-weeks-in-subjects-with-type-2-diabetes-5949https://curecurrent.com/trials/glycemic-efficacy-and-renal-safety-study-of-dapagliflozin-in-subjects-with-type-2-diabetes-mellitus-and-moderate-renal-i-5950https://curecurrent.com/trials/a-randomized-control-trial-comparing-linjeta-versus-humalog-in-pumps-effect-on-postprandial-blood-sugars-5951https://curecurrent.com/trials/evaluation-of-an-investigational-blood-glucose-monitoring-system-5952https://curecurrent.com/trials/single-dose-pharmacokinetics-of-repaglinide-metformin-and-combination-tablet-in-fed-healthy-volunteers-5953https://curecurrent.com/trials/a-study-for-pre-diabetic-patients-with-cholesterol-lowering-drugs-5954https://curecurrent.com/trials/effect-of-repaglinide-and-metformin-combination-tablet-or-rosiglitazone-and-metformin-in-fixed-dose-combination-on-blood-5955https://curecurrent.com/trials/single-dose-pharmacokinetics-of-repaglinide-metformin-and-combination-tablet-in-healthy-volunteers-5956https://curecurrent.com/trials/assessing-inherited-markers-of-metabolic-syndrome-in-the-young-5957https://curecurrent.com/trials/comparison-of-nn1250-versus-insulin-glargine-in-subjects-with-type-2-diabetes-5958https://curecurrent.com/trials/monitoring-the-infusion-pressure-in-insulin-infusion-sets-in-healthy-adults-5959https://curecurrent.com/trials/comparison-of-nn1250-with-insulin-glargine-in-type-1-diabetes-5960https://curecurrent.com/trials/clinical-evaluation-of-bd-next-pen-needle-5961https://curecurrent.com/trials/managing-wounds-with-allevyn-life-in-a-home-health-care-environment-5962https://curecurrent.com/trials/the-efficacy-and-safety-of-liraglutide-adjunct-to-insulin-treatment-in-type-1-diabetes-5963https://curecurrent.com/trials/anti-diabetic-effects-of-liraglutide-in-adolescents-and-young-subjects-with-type-1-diabetes-5964https://curecurrent.com/trials/evaluation-of-a-diabetes-vaccine-in-newly-diagnosed-diabetics-5965https://curecurrent.com/trials/ascertainment-of-emr-based-clinical-covariates-among-patients-receiving-oral-and-non-insulin-injected-hypoglycemic-thera-5966https://curecurrent.com/trials/treatment-with-hokt3gamma1-ala-ala-in-t1dm-5967https://curecurrent.com/trials/proleukin-and-rapamune-in-type-1-diabetes-5968https://curecurrent.com/trials/the-management-of-glucocorticoid-induced-hyperglycemia-in-hospitalized-patients-5969https://curecurrent.com/trials/single-dose-study-to-evaluate-safety-tolerability-and-pharmacodynamics-of-remd-477-in-subjects-with-type-1-diabetes-mell-5970https://curecurrent.com/trials/vildagliptin-compared-to-pioglitazone-in-combination-with-metformin-in-patients-with-type-2-diabetes-5971https://curecurrent.com/trials/comparison-of-two-treatments-for-multivessel-coronary-artery-disease-in-individuals-with-diabetes-freedom-5972https://curecurrent.com/trials/effects-of-hyperglycemia-during-cardiopulmonary-bypass-on-renal-function-5973https://curecurrent.com/trials/arterial-stiffness-in-type-i-diabetes-mellitus-5974https://curecurrent.com/trials/text-messaging-to-promote-walking-among-latino-adults-at-risk-for-peripheral-arterial-disease-5975https://curecurrent.com/trials/mechanisms-of-diabetes-relapse-after-bariatric-surgery-5976https://curecurrent.com/trials/the-effect-of-ly333531-on-protein-in-the-urine-in-patients-with-type-2-diabetes-5977https://curecurrent.com/trials/multiple-dose-study-of-pf-04937319-in-patients-with-type-2-diabetes-5978https://curecurrent.com/trials/safety-and-efficacy-of-endobarrier-in-subjects-with-type-2-diabetes-who-are-obese-5979https://curecurrent.com/trials/roflumilast-plus-alogliptin-proof-of-mechanism-study-in-type2-diabetes-5980https://curecurrent.com/trials/phase-2-study-to-evaluate-safety-and-efficacy-of-investigational-drug-pf04937319-in-patients-with-type-2-diabetes-5981https://curecurrent.com/trials/study-to-understand-efficacy-and-safety-of-investigational-agent-pf-04937319-compared-to-approved-agent-glimepiride-in-p-5982https://curecurrent.com/trials/comparison-of-self-adjustment-versus-standard-of-care-treatment-in-subjects-with-type-2-diabetes-5983https://curecurrent.com/trials/comparison-of-insulin-detemir-with-insulin-glargine-in-type-2-diabetes-5984https://curecurrent.com/trials/mitochondrial-related-platelet-transcript-expression-levels-in-pre-diabetic-subjects-randomized-to-metformin-or-placebo-5985https://curecurrent.com/trials/comparison-of-insulin-detemir-morning-insulin-detemir-evening-and-nph-insulin-evening-in-patients-with-type-2-diabetes-5986https://curecurrent.com/trials/canagliflozin-treatment-and-trial-analysis-sulfonylurea-cantata-su-sglt2-add-on-to-metformin-versus-glimepiride-5987https://curecurrent.com/trials/mobile-technology-online-tools-to-track-adherence-in-chronic-illness-patients-5988https://curecurrent.com/trials/study-to-evaluate-the-effect-of-bydureon-on-24-hour-glucose-control-in-metformin-treated-patients-with-type-2-diabetes-5989https://curecurrent.com/trials/safety-and-efficacy-of-insulin-detemir-plus-insulin-aspart-against-insulin-glargine-plus-insulin-aspart-as-mealtime-insu-5990https://curecurrent.com/trials/a-study-to-evaluate-cardiovascular-outcomes-in-patients-with-type-2-diabetes-treated-with-itca-650-5991https://curecurrent.com/trials/comparison-of-insulin-detemir-or-insulin-glargine-as-add-on-to-oral-antidiabetic-drugs-in-type-2-diabetes-5992https://curecurrent.com/trials/comparison-of-insulin-detemir-plus-insulin-aspart-against-insulin-glargine-plus-insulin-aspart-in-type-2-diabetes-5993https://curecurrent.com/trials/pharmacokinetics-of-insulin-detemir-in-subjects-with-type-2-diabetes-5994https://curecurrent.com/trials/a-study-to-examine-changes-in-gip-plasma-levels-following-gastric-bypass-surgery-in-obese-patients-5995https://curecurrent.com/trials/efficacy-and-safety-of-metformin-and-liraglutide-in-obese-subjects-with-type-2-diabetes-previously-treated-with-an-oral-5996https://curecurrent.com/trials/effect-of-liraglutide-on-the-beta-cell-responsiveness-in-subjects-with-type-2-diabetes-compared-to-a-healthy-control-gro-5997https://curecurrent.com/trials/examination-of-the-effects-of-liraglutide-on-the-mode-of-action-of-insulin-detemir-5998https://curecurrent.com/trials/a-study-of-bms-512148-dapagliflozin-in-patients-with-type-2-diabetes-and-inadequately-controlled-hypertension-on-an-angi-5999https://curecurrent.com/trials/pk-pd-study-of-gan-lee-s-insulin-glargine-injection-in-comparison-to-lantus-in-type-1-diabetes-6000